Familial hypercholesterolemia

E4_FH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E78.00 Hospital discharge: ICD-9 — 2720A Cause of death: ICD-10 — E78.00 Cause of death: ICD-9 — 2720A 2 out of 7 registries used, show all original rules.	6720
4. Check minimum number of events None	6720
5. Include endpoints None	6720
6. Filter based on genotype QC (FinnGen only)	6720

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF6v3

NAME	E4_FH
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E7800
HD_ICD_9	2720A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E7800
COD_ICD_9	2720A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Familial hypercholesterolemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Familial hypercholesterolemia, with ischemic heart disease

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	51090	24106	26865
Only index persons	48827	23192	25635
Unadjusted period prevalence (%)
Whole population	0.72	0.69	0.75
Only index persons	0.92	0.85	0.98
Median age at first event (years)
Whole population	68.34	71.31	65.66
Only index persons	68.32	71.27	65.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6720	2784	3936
Unadjusted period prevalence (%)	1.41	0.95	1.74
Median age at first event (years)	65.64	66.06	65.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6045: Matched controls
60450

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

15.6

323.0

2820

3201

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

40.1

323.0

572

157

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

4.2

323.0

2496

8710

C10AA01

ATC

simvastatin; oral

6.2

323.0

4633

20828

I10

ICD-10 Finland

Essential (primary) hypertension

4.3

323.0

4837

29218

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

5.5

323.0

1110

2383

AN1

Coronary angiography

5.2

323.0

1701

4199

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.4

323.0

2701

9375

C10AA07

ATC

rosuvastatin; oral

3.6

323.0

2281

8616

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

18.3

323.0

1246

843

B01AC04

ATC

clopidogrel; oral

4.9

323.0

2028

5598

C10AX09

ATC

ezetimibe; oral

6.2

323.0

1433

2898

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.4

323.0

2463

10091

C10AA05

ATC

atorvastatin; oral

4.7

323.0

3879

16616

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

5.2

323.0

1136

2588

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

4.1

323.0

2259

7672

C01DA14

ATC

isosorbide mononitrate; oral

3.7

323.0

1835

6340

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4503599627370496.0

323.0

6007

152

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.2

320.1

2206

9153

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.4

319.0

1317

3561

C07AB07

ATC

bisoprolol; oral

2.8

313.1

3819

22866

211

Kela drug reimbursment

Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)

59.5

308.0

364

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

5.5

267.7

872

1803

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.8

239.5

2022

9209

I25.2

ICD-10 Finland

Old myocardial infarction

4.5

232.1

910

2277

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.8

224.3

1877

8434

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

5.5

218.6

698

1393

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

218.1

1970

9233

A10BA02

ATC

metformin; oral

2.5

213.4

2288

11780

103

Kela drug reimbursment

Diabetes, insulin-treated

2.5

212.0

2199

11111

T90

ICPC

Diabetes non-insulin dependent

2.6

209.9

1942

9190

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

207.9

2087

10329

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

6.9

207.0

553

875

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.6

201.9

553

905

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.7

201.8

622

1185

I20.00

ICD-10 Finland

Unstable angina

6.9

201.6

534

834

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

4.9

197.9

703

1574

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.7

195.6

967

2956

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

5.0

186.0

648

1416

C10AA04

ATC

fluvastatin; oral

3.5

183.0

953

3027

C03CA01

ATC

furosemide; systemic

2.3

180.7

2440

13809

C09AA05

ATC

ramipril; oral

2.4

180.7

2092

10980

I20.09

ICD-10 Finland

Unstable angina

4.5

172.6

674

1653

N02BE01

ATC

paracetamol; systemic, rectal

2.8

172.1

5304

43634

Angiography of the heart and coronary arteries

3.8

171.1

800

2315

C08CA01

ATC

amlodipine; oral

2.2

169.1

2707

16417

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

161.6

1317

5645

AN4

Balloon angioplasty and drug eluding stent

6.0

160.8

472

839

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.5

159.0

616

1494

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

158.4

3043

19764

205

Kela drug reimbursment

Chronic hypertension

2.2

155.6

2341

13659

A10AE04

ATC

insulin glargine; parenteral

3.4

154.0

837

2723

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.2

153.1

936

3319

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

150.6

1378

6276

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

2.6

146.9

1327

5991

SPAT1262

SPAT

Handing over of treatment supplies

2.4

146.8

1470

7014

XF402

NOMESCO Finland

ECG with work load test

2.9

141.0

958

3633

I20.90

ICD-10 Finland

Angina pectoris, unspecified

5.0

138.3

478

1025

AN3

Balloon angioplasty and metallic stent

6.2

138.2

396

680

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

17.7

136.8

219

128

C10AA03

ATC

pravastatin; oral

3.5

136.3

701

2172

AA1AD

NOMESCO Finland

CT of head and brain

2.2

135.8

1771

9552

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

135.6

939

3598

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.1

129.6

2118

12543

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.3

128.7

721

2378

C10AA02

ATC

lovastatin; oral

4.3

126.5

513

1290

A02BC02

ATC

pantoprazole; systemic

1.9

126.0

3962

29924

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.4

125.1

671

2141

B04AB02

ATC

6.8

124.1

328

504

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

120.8

652

2088

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.4

116.2

616

1943

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.7

115.0

549

1592

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.9

111.3

489

1319

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

110.9

1336

6846

R06.0

ICD-10 Finland

Dyspnoea

2.1

110.4

1677

9498

C07AB02

ATC

metoprolol; systemic

2.1

108.5

1636

9227

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

3.9

107.1

472

1276

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

4.0

106.6

453

1185

I20.01

ICD-10 Finland

Unstable angina

4.9

105.7

364

773

E66.00

ICD-10 Finland

Metabolic syndrome

4.2

105.5

430

1082

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5.3

105.4

340

671

J01DB01

ATC

cefalexin; oral

2.0

104.6

4719

39011

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.0

104.4

678

2463

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

99.2

1145

5713

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

97.2

1202

6182

SPAT1263

SPAT

Sampling

1.8

96.2

2594

17858

SPAT1254

SPAT

Administration of medicine

2.2

95.3

1110

5549

A28

ICPC

Limited function/disability NOS

2.1

93.9

1201

6256

Single vessel balloon catheter extension

5.4

93.2

296

573

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

91.7

1983

12634

N03AX16

ATC

pregabalin; oral

2.0

91.3

1451

8258

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

89.8

1151

5988

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

88.6

1845

11568

A10BH01

ATC

sitagliptin; oral

2.5

88.2

746

3163

G47.3

ICD-10 Finland

Sleep apnoea

2.0

87.7

1306

7224

AA1

Conventional CABG

5.7

87.6

265

484

A10AE05

ATC

insulin detemir; parenteral

3.5

84.5

426

1282

N02AX02

ATC

tramadol; systemic, rectal

1.7

84.0

2596

18387

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.0

82.9

516

1810

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

5.0

81.4

275

570

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.9

80.9

210

314

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

80.5

1901

12342

R42

ICD-10 Finland

Dizziness and giddiness

1.9

78.8

1425

8437

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.1

78.5

476

1638

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

78.4

1790

11472

388

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

767.9

77.5

B01AA03

ATC

warfarin; systemic

1.8

77.2

1606

9971

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.4

77.1

399

1224

E66.01

ICD-10 Finland

Obesity due to excess calories

3.4

76.3

400

1239

E86

ICD-10 Finland

Volume depletion

19.8

75.3

115

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

5.0

75.3

256

534

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

74.2

490

1781

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.7

74.1

545

2122

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

72.8

2564

18588

M79.6

ICD-10 Finland

Pain in limb

1.7

72.5

1960

13168

292

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

716.6

72.3

A10BB12

ATC

glimepiride; oral

2.5

71.6

624

2670

L28

ICPC

Limited function/disability (L)

2.0

71.6

1099

6092

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.4

71.6

375

1160

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

22.2

71.4

105

280

Kela drug reimbursment

Clopidogrel

6.0

69.7

200

342

I25

ICD-10 Finland

Chronic ischaemic heart disease

3.0

67.2

417

1454

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.5

66.7

336

1007

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.3

65.8

353

1111

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

65.5

898

4744

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

65.2

1579

10189

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

7.2

64.8

163

233

2720A

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA FAMILIARIS (FHK)]

+∞

64.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

63.2

1121

6520

C10AC02

ATC

colestipol; oral

20.3

62.2

R53

ICD-10 Finland

Malaise and fatigue

1.8

61.8

1162

6891

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

61.8

1241

7525

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

61.8

511

2121

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

61.4

1591

10443

C10AB05

ATC

fenofibrate; oral

5.9

61.0

177

307

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

60.2

1055

6098

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

59.8

322

1015

WX872

NOMESCO Finland

Intensive care

3.0

59.6

379

1339

B01AB05

ATC

enoxaparin; parenteral

1.6

59.5

1878

13009

AN2

Balloon angioplasty, including several vessels

3.7

59.1

277

783

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

58.8

1780

12180

C03AA03

ATC

hydrochlorothiazide; oral

2.1

58.6

707

3523

E87.6

ICD-10 Finland

Hypokalaemia

8.1

58.4

135

170

M04AA01

ATC

allopurinol; systemic

1.9

58.3

958

5403

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

58.3

960

5421

J01FF01

ATC

clindamycin; systemic

1.7

58.0

1515

9939

C03DA01

ATC

spironolactone; oral

2.1

57.9

744

3809

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

57.9

2258

16501

J01MA12

ATC

levofloxacin; systemic

1.8

57.2

1192

7292

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

56.9

2144

15510

C10AX13

ATC

evolocumab; parenteral

52.8

56.9

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.7

56.7

258

712

C08CA13

ATC

lercanidipine; oral

1.9

56.5

887

4916

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.4

56.3

295

911

N02AA05

ATC

oxycodone; systemic

1.9

56.3

1023

5974

H02AB06

ATC

prednisolone; systemic

1.6

56.1

2640

20142

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.5

55.8

205

464

C10AB02

ATC

bezafibrate; oral

5.9

55.5

160

276

SPAT1325

SPAT

Vaccination

1.6

55.3

2214

16229

C09AA02

ATC

enalapril; systemic

1.7

55.3

1368

8810

M10.9

ICD-10 Finland

Gout, unspecified

2.4

55.2

505

2207

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

5.0

54.4

181

369

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.4

54.1

204

474

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.2

54.1

299

961

R07.3

ICD-10 Finland

Other chest pain

2.2

53.7

597

2863

M54.5

ICD-10 Finland

Low back pain

1.6

53.5

1650

11292

N03AX12

ATC

gabapentin; oral

1.9

53.3

888

5020

E87.5

ICD-10 Finland

Hyperkalaemia

14.5

52.7

S18

ICPC

Laceration/cut

1.5

52.1

2495

18993

E78.10

ICD-10 Finland

Familial hypertriglyceridemia

+∞

52.1

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

7.1

52.1

131

188

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

51.8

729

3863

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

51.5

985

5836

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

51.4

1781

12533

C09CA01

ATC

losartan; oral

1.6

51.3

1500

10094

R55

ICD-10 Finland

Syncope and collapse

2.0

50.8

716

3794

R51.80

ICD-10 Finland

Headache

2.0

49.3

673

3522

UJF32

NOMESCO Finland

Coloscopy

1.6

49.2

1546

10583

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.5

49.1

417

1750

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

49.0

453

1986

A10BK03

ATC

empagliflozin; oral

2.4

49.0

436

1875

WX722

NOMESCO Finland

PEEP

2.7

48.5

353

1356

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

48.4

453

1999

SPAT1216

SPAT

Assessment of functional ability

1.7

48.3

1068

6613

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

48.1

701

3758

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.7

48.0

221

616

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

48.0

772

4297

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

47.9

1349

8958

I50.0

ICD-10 Finland

Congestive heart failure

2.1

47.9

559

2738

K90

ICPC

Stroke/cerebrovascular accident

3.5

47.5

232

678

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

4.9

47.5

162

340

SPAT1310

SPAT

Counselling related to known health issue

1.6

47.3

1791

12823

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

46.8

1884

13680

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.1

46.6

265

868

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.8

46.0

158

334

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

45.8

622

3239

B01AC07

ATC

dipyridamole; systemic

2.5

45.7

392

1652

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

45.6

2140

16070

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

4.0

45.5

189

482

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

45.4

794

4547

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

45.3

1168

7548

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

5.0

45.3

149

301

SPAT1252

SPAT

Overall medication plan or its review

2.2

45.0

511

2469

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.7

44.7

206

575

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

44.5

968

5949

A10BH05

ATC

linagliptin; oral

2.6

44.4

353

1427

A46

ICD-10 Finland

Erysipelas

1.8

43.9

891

5355

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.2

43.6

468

2201

SPAT1229

SPAT

Assessment of need for aid

2.1

43.6

550

2781

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

43.3

804

4691

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

43.3

1032

6513

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

4.7

43.3

151

325

R03AC02

ATC

salbutamol; inhalant

1.5

43.2

2615

20657

A02BC05

ATC

esomeprazole; systemic

1.5

43.2

2160

16391

J01MA02

ATC

ciprofloxacin; systemic

1.5

43.0

2264

17367

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

42.7

672

3699

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.8

42.4

146

310

A02BC01

ATC

omeprazole; systemic

1.6

42.3

1591

11310

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.3

42.1

223

694

B04AD02

ATC

23.3

41.8

P01AB01

ATC

metronidazole; oral, rectal

1.5

41.7

1905

14145

ZX120

NOMESCO Finland

Intravenous

2.0

41.6

566

2948

SPAT1153

SPAT

Removal of sutures

1.5

41.6

1925

14335

T89

ICPC

Diabetes insulin dependent

3.5

41.5

200

579

160

Kela drug reimbursment

exenatide

4.4

41.5

155

358

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

41.4

624

3378

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

41.4

265

939

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

41.3

654

3607

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

41.1

372

1612

E66.8

ICD-10 Finland

Other obesity

3.2

41.0

224

714

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.4

40.9

153

354

SPAT1097

SPAT

Recording of ECG

1.7

40.3

957

6020

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.0

40.0

166

424

H25.8

ICD-10 Finland

Other senile cataract

1.8

39.9

800

4776

207

Kela drug reimbursment

Chronic arrhythmias

1.7

39.8

1019

6547

SPAT1301

SPAT

No procedures

1.5

39.6

1862

13874

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

39.0

2440

19267

Coronary artery bypass surgery

3.2

39.0

211

668

ZXA05

NOMESCO Finland

Left side

1.5

38.9

1510

10774

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.8

38.9

260

948

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

38.8

943

5961

E78.40

ICD-10 Finland

Familial combined hyperlipidaemia

137.5

38.7

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.2

38.6

210

668

R11

ICD-10 Finland

Nausea and vomiting

2.2

38.4

427

2040

J01CA04

ATC

amoxicillin; systemic

1.5

38.3

4175

36611

B04AB01

ATC

4.5

38.2

141

322

M48.0

ICD-10 Finland

Spinal stenosis

1.8

38.2

801

4846

A10BX01

ATC

guar gum; systemic

2.6

38.1

300

1206

C02AC05

ATC

moxonidine; oral

2.6

38.0

294

1170

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.0

37.9

501

2576

S97

ICPC

Chronic ulcer skin

2.3

37.7

374

1696

I20.91

ICD-10 Finland

Angina pectoris, unspecified

4.5

37.6

136

305

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

37.5

490

2508

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.1

37.4

151

376

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

37.3

461

2306

UKC02

NOMESCO Finland

Cystoscopy

1.6

37.3

1093

7271

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.9

37.3

126

263

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

37.2

776

4685

E78.49

ICD-10 Finland

Other hyperlipidaemia

10.5

37.1

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

36.9

2646

21369

315

Kela drug reimbursment

Clopidogrel

5.1

36.7

118

233

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

36.7

815

5012

N05CF01

ATC

zopiclone; oral

1.5

36.7

1827

13730

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

6.3

36.6

100

162

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.1

36.6

210

693

WX110

NOMESCO Finland

Local anesthesy

1.4

36.6

3424

29025

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

36.3

3359

28391

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.7

36.1

126

272

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

36.1

471

2408

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

36.1

392

1852

N06AX11

ATC

mirtazapine; oral

1.5

36.1

1572

11477

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.4

35.9

133

305

A10BJ06

ATC

semaglutide; parenteral

3.3

35.6

188

585

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

35.4

889

5662

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

35.3

802

4960

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

8.6

35.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

35.1

416

2044

A06AD11

ATC

lactulose; oral

1.7

35.1

920

5928

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

35.0

767

4695

A04

ICPC

Weakness/tiredness general

1.8

34.7

713

4279

N06AX21

ATC

duloxetine; oral

2.0

34.6

486

2553

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

7.2

34.4

120

WX882

NOMESCO Finland

High dependency care

3.1

34.4

197

650

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

34.1

381

1823

L03

ICPC

Low back symptom/complaint

1.6

34.1

1185

8200

ZXA00

NOMESCO Finland

Right side

1.5

34.1

1581

11671

C09CA03

ATC

valsartan; oral

1.9

34.0

546

3018

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

33.9

450

2316

N05BA04

ATC

oxazepam; oral

1.5

33.5

1252

8806

PE1AT

NOMESCO Finland

Femoral artery PTA

4.7

33.4

117

254

Catheterization and pressure measurement of the left side of the heart

3.5

33.4

164

483

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.9

33.4

209

732

J01AA02

ATC

doxycycline; systemic

1.4

33.0

4242

37701

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.3

33.0

EBA00

NOMESCO Finland

Extraction of tooth

1.5

33.0

1619

12073

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.1

33.0

107

214

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

32.9

2232

17717

H36.01

ICD-10 Finland

Diabetic maculopathy

5.2

32.8

103

199

C07AG02

ATC

carvedilol; oral

2.0

32.7

418

2116

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

32.7

529

2930

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

32.6

469

2487

C08CA02

ATC

felodipine; oral

1.8

32.5

638

3770

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

32.4

409

2059

WX892

NOMESCO Finland

Monitored bed care

2.0

32.4

438

2267

SPAT1255

SPAT

Intravenous administration of medicine

2.0

32.4

417

2117

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

6.1

32.2

147

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

32.1

2386

19228

N30.0

ICD-10 Finland

Acute cystitis

1.7

31.9

696

4248

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

31.8

445

2336

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

31.6

539

3038

A10BJ02

ATC

liraglutide; parenteral

3.6

31.6

148

420

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

31.5

959

6409

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

31.5

266

1111

P20

ICPC

Memory disturbance

1.6

31.3

845

5473

C09BA02

ATC

enalapril and diuretics; systemic

1.8

31.3

554

3163

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

31.1

351

1686

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

4.3

31.1

119

283

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

31.0

1242

8853

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

30.9

490

2691

E78.21

ICD-10 Finland

Remnant hyperlipidemia

314.4

30.8

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.5

30.8

112

253

C10AB04

ATC

gemfibrozil; oral

5.3

30.8

180

N06AB04

ATC

citalopram; systemic

1.6

30.6

1033

7075

A02BC03

ATC

lansoprazole; oral

1.4

30.6

1604

12085

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

30.3

433

2289

K92.1

ICD-10 Finland

Melaena

2.1

30.3

344

1654

B01AC24

ATC

ticagrelor; oral

2.7

30.3

215

816

2720X

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA ALIA]

+∞

30.2

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

30.2

1038

7138

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

30.2

869

5721

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

29.9

572

3345

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

29.8

620

3726

XF404

NOMESCO Finland

Ambulatory ECG

1.8

29.8

539

3097

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.4

29.7

151

458

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

29.6

832

5439

A29

ICPC

General symptom/complaint other

1.7

29.6

646

3938

K29

ICPC

Cardiovascular sympt/complt other

2.3

29.5

297

1351

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

29.5

312

1456

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

29.4

2923

24606

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

29.3

582

3449

E78.11

ICD-10 Finland

Other hypertriglyceridemia

16.3

29.3

N05AH04

ATC

quetiapine; oral

1.7

29.2

688

4287

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

29.1

1579

11952

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

5.5

29.1

163

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

29.1

746

4761

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

29.0

846

5584

K02.1

ICD-10 Finland

Caries of dentine

1.4

28.9

2548

21013

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3.3

28.7

151

470

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

28.7

286

1297

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.4

28.7

162

Z00.0

ICD-10 Finland

General medical examination

1.5

28.7

997

6866

A10BD07

ATC

metformin and sitagliptin; systemic

2.3

28.4

275

1231

111

Conventional CABG

5.4

28.4

160

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

28.3

185

667

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

5.9

28.3

137

M10.0

ICD-10 Finland

Idiopathic gout

2.5

28.1

223

902

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

28.0

3397

29427

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

27.9

286

1313

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.8

27.9

120

318

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

4.1

27.9

110

270

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.3

27.9

147

459

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.9

27.8

178

634

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

27.8

551

3260

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

27.7

341

1699

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.5

27.7

134

392

N19

ICD-10 Finland

Unspecified kidney failure

2.5

27.6

226

931

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

27.5

445

2459

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

27.5

225

925

C08CA05

ATC

nifedipine; systemic

1.9

27.5

416

2245

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.5

27.4

131

379

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

27.3

383

2009

A10BK01

ATC

dapagliflozin; oral

2.4

27.3

247

1070

G44.2

ICD-10 Finland

Tension-type headache

1.8

27.1

540

3197

E83.50

ICD-10 Finland

Hypercalcemia

8.9

27.1

A02BA02

ATC

ranitidine; systemic

1.5

27.1

1127

8070

V03AE01

ATC

polystyrene sulfonate; oral

4.5

27.1

217

C09AA04

ATC

perindopril; oral

2.0

27.0

341

1717

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

27.0

231

972

SPAT1236

SPAT

Informing family of child’s disability

3.1

26.9

153

502

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.9

26.7

112

291

B01AF02

ATC

apixaban; oral

1.7

26.6

620

3846

J01DA01

ATC

[U] cefalexin; systemic

1.3

26.6

3210

27670

-1

NOMESCO Finland

1.4

26.5

1439

10858

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.4

26.4

132

396

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

26.4

532

3161

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.5

26.3

210

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

26.3

344

1759

L17

ICPC

Foot/toe symptom/complaint

1.4

26.2

1292

9567

FL1AC

NOMESCO Finland

Left cardioangiography

3.4

26.2

128

377

M03BX02

ATC

tizanidine; oral

1.3

26.2

2858

24235

C09CA06

ATC

candesartan; oral

1.5

26.2

1085

7755

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

10.1

26.1

WZA90

NOMESCO Finland

Other doctors statement

1.5

26.1

1072

7647

Z71.8

ICD-10 Finland

Other specified counselling

1.5

26.1

1042

7387

WZC30

NOMESCO Finland

Teaching

1.6

26.0

690

4436

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

25.8

429

2392

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

25.8

226

963

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

25.8

2013

16177

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.1

25.8

302

1473

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

25.5

307

1515

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.1

25.3

242

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

25.2

2428

20150

A10AE06

ATC

insulin degludec; parenteral

3.1

25.2

144

474

A10AA02

ATC

2.6

25.2

184

711

N06AB10

ATC

escitalopram; oral

1.6

25.0

748

4955

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

24.9

772

5159

M25.5

ICD-10 Finland

Pain in joint

1.4

24.9

1242

9206

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.7

24.8

172

644

SPAT1104

SPAT

Monitoring of emergency patient

1.9

24.7

392

2151

C10AX14

ATC

alirocumab; parenteral

251.1

24.7

A10AA01

ATC

3.3

24.6

126

386

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

24.5

726

4797

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

24.5

676

4389

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

24.4

1254

9338

C09DA01

ATC

losartan and diuretics; oral

1.7

24.4

590

3693

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

24.4

483

2853

KMAK

NOMESCO Finland

1.3

24.4

2286

18862

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

24.3

231

1026

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

24.3

509

3056

162

Kela drug reimbursment

liraglutide

4.6

24.3

191

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

24.3

623

3965

XF640

NOMESCO Finland

2.5

24.2

191

771

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

24.2

279

1353

A11CC03

ATC

alfacalcidol; systemic

3.1

24.0

135

442

N06AA09

ATC

amitriptyline; systemic

1.7

24.0

530

3235

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.5

24.0

193

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

23.9

483

2871

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.3

23.8

221

970

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.2

23.8

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

23.6

365

1983

R03BB04

ATC

tiotropium bromide; inhalant

1.6

23.4

605

3858

R07.2

ICD-10 Finland

Precordial pain

3.0

23.3

135

451

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

23.3

172

670

A10BX07

ATC

[U] liraglutide; parenteral

4.2

23.3

218

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

23.2

577

3639

E66.9

ICD-10 Finland

Obesity, unspecified

2.8

23.1

151

547

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.4

23.0

112

330

K78

ICPC

Atrial fibrillation/flutter

1.7

23.0

541

3359

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

20.1

22.9

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

22.9

133

446

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

22.7

1669

13210

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

22.7

255

1222

H3603, E103

ICD-10 Finland

6.5

22.7

B04AC04

ATC

5.4

22.7

130

SPAT1260

SPAT

Consultation of another employee

1.5

22.6

934

6646

SPAT1211

SPAT

Application of soft bandage

1.7

22.6

500

3051

E87.2

ICD-10 Finland

Acidosis

230.7

22.6

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

22.5

424

2462

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

22.2

198

853

R60.0

ICD-10 Finland

Localized oedema

1.6

22.2

607

3923

SPAT1285

SPAT

Provision of consultation response

2.0

22.2

304

1580

AA2

Off pump CABG sternotomy

6.3

22.2

R02

ICPC

Shortness of breath/dyspnoea

1.6

22.2

614

3980

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

22.2

137

479

R50.9

ICD-10 Finland

Fever, unspecified

1.6

22.1

684

4560

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.1

22.0

126

417

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

22.0

226

1043

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

22.0

174

704

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.6

22.0

165

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

5.3

21.9

127

Multi-vessel balloon catheter extension

5.3

21.9

127

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

21.9

353

1946

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

21.9

705

4746

K84

ICPC

Heart disease other

2.5

21.9

179

735

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

21.9

756

5171

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

21.8

275

1382

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

21.8

341

1864

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.2

21.8

114

356

B04AC02

ATC

6.8

21.7

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.7

21.7

448

2676

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.1

21.7

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

21.7

175

715

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.7

21.7

268

R06.2

ICD-10 Finland

Wheezing

2.2

21.7

218

996

AP1

Catheterization of the left side of the heart

3.0

21.6

130

445

R4110

NOMESCO Finland

Physiotherapy

1.4

21.6

1311

10036

C01BD01

ATC

amiodarone; systemic

2.3

21.6

198

864

A10BH02

ATC

vildagliptin; oral

2.7

21.6

151

571

TK800

NOMESCO Finland

Hemodialysis

3.0

21.5

127

432

Z01.2

ICD-10 Finland

Dental examination

1.3

21.4

1772

14266

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.6

21.4

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.2

21.4

127

E78.2

ICD-10 Finland

Mixed hyperlipidaemia

13.9

21.2

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

21.2

294

1536

J01FA06

ATC

roxithromycin; oral

1.3

21.2

1957

16017

K76

ICPC

Ischaemic heart dis without angina

2.5

21.2

173

713

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

5.8

21.2

104

C08DB01

ATC

diltiazem; oral

1.8

21.2

353

1972

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

21.2

275

1401

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.7

21.2

253

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.8

21.1

137

492

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

21.1

589

3829

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

21.1

201

896

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

21.0

1741

14013

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.9

21.0

322

1746

C07AB08

ATC

celiprolol; oral

2.4

20.9

188

811

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.3

20.9

179

Z50.1

ICD-10 Finland

Other physical therapy

1.9

20.8

305

1627

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

20.7

296

1564

N06AX16

ATC

venlafaxine; oral

1.6

20.6

501

3138

I50.1

ICD-10 Finland

Left ventricular failure

1.9

20.5

298

1585

SPAT1234

SPAT

Support of social functional capacity

1.9

20.4

306

1645

C09DA06

ATC

candesartan and diuretics; oral

1.8

20.4

389

2269

J01CA08

ATC

pivmecillinam; oral

1.3

20.3

1594

12708

C02EA02

ATC

1.9

20.3

307

1655

C10AC01

ATC

colestyramine; oral

2.6

20.1

146

564

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.2

20.1

WX320

NOMESCO Finland

Spinalanesthesy

1.4

20.0

1188

9042

H3600, E103

ICD-10 Finland

6.3

19.9

WZC30

SPAT

3.0

19.9

118

403

I20.10

ICD-10 Finland

Angina angiospastic

5.8

19.8

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.4

19.8

172

732

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.0

19.8

126

SPAT1167

SPAT

Insertion of urinary catheter

2.1

19.6

225

1092

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

19.5

357

2056

K92

ICPC

Atherosclerosis/periph vascular dis

3.4

19.4

288

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

19.4

339

1925

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

19.4

754

5290

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

19.3

1593

12780

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

12.7

19.3

M01AX17

ATC

nimesulide; oral

1.4

19.3

1321

10288

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

19.2

327

1840

B04AD01

ATC

13.3

19.1

K28

ICPC

Limited function/disability (K)

2.6

19.1

145

572

A10AB06

ATC

insulin glulisine; parenteral

4.4

19.1

162

NHQ40

NOMESCO Finland

Amputation of toe

2.9

19.1

116

402

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

8.6

19.1

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.7

19.1

134

508

A10BX04

ATC

[U] exenatide; parenteral

4.2

19.0

172

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.6

19.0

141

551

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

18.9

360

2101

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

18.9

839

6043

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

2.0

18.9

240

1214

L13

ICPC

Hip symptom/complaint

1.5

18.9

823

5910

SPAT1059

SPAT

Spirometry at the office

1.9

18.8

283

1523

R2110

NOMESCO Finland

Giving the first information

1.9

18.8

277

1481

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

18.8

125

459

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

18.8

325

1838

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

5.8

18.8

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

18.7

604

4063

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

17.1

18.7

A11

ICPC

Chest pain NOS

1.7

18.5

389

2336

A01

ICPC

Pain general/multiple sites

1.7

18.5

377

2245

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

18.4

393

2371

I95.9

ICD-10 Finland

Hypotension, unspecified

3.3

18.4

295

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.2

18.4

164

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.9

18.4

A10BG03

ATC

pioglitazone; oral

2.4

18.3

157

666

S06.0

ICD-10 Finland

Concussion

1.6

18.3

471

2995

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.6

18.2

138

E0000UV

ATC

1.3

18.2

1835

15128

N18.0

ICD-10 Finland

End-stage renal disease

3.7

18.2

219

E78.8

ICD-10 Finland

Other disorders of lipoprotein metabolism

25.1

18.2

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

18.2

551

3649

SPAT1240

SPAT

Therapeutic discussion

1.8

18.1

351

2055

J01EA01

ATC

trimethoprim; systemic

1.4

18.1

1175

9059

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

18.1

152

635

H3601, E103

ICD-10 Finland

5.9

18.1

R04.0

ICD-10 Finland

Epistaxis

1.7

18.1

408

2503

K91

ICPC

Cerebrovascular disease

3.4

17.9

258

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

17.9

262

1399

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.3

17.8

275

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

17.8

1170

9033

H03AA01

ATC

levothyroxine sodium; systemic

1.4

17.8

1029

7778

SPAT1312

SPAT

General health counselling

1.3

17.8

1563

12623

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

17.8

168

747

H3601, E113

ICD-10 Finland

3.0

17.8

104

353

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

17.8

1967

16414

2722A

ICD-9 Finland

Disorders of lipoid metabolism, Mixed hyperlipidaemia

+∞

17.7

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

4.4

17.7

147

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

17.7

268

1450

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.9

17.5

182

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.7

17.4

212

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

17.4

505

3311

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.6

17.3

489

3180

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.1

17.3

169

WW500

NOMESCO Finland

Blood transfusion

2.0

17.3

212

1056

I20.08

ICD-10 Finland

Unstable angina

10.4

17.1

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

17.1

1459

11726

K30

ICD-10 Finland

Functional dyspepsia

1.6

17.1

446

2845

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.5

17.0

222

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

17.0

337

1991

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

17.0

485

3166

SPAT1053

SPAT

Memory test

1.4

16.9

1003

7605

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

16.9

275

1526

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

16.8

156

688

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.5

16.8

SPAT1360

SPAT

Extensive global examination

1.6

16.7

403

2516

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

16.7

458

2957

K77

ICPC

Heart failure

2.4

16.7

140

586

R31

ICD-10 Finland

Unspecified haematuria

1.5

16.7

591

4055

A10BG02

ATC

rosiglitazone; oral

2.9

16.7

102

356

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.7

16.6

115

432

XCK00

NOMESCO Finland

Perimetry

1.7

16.6

377

2315

XG405

NOMESCO Finland

Education on PEF monitoring

3.2

16.6

280

XF409

NOMESCO Finland

Other special ECG

4.8

16.6

116

XG466

NOMESCO Finland

Sleep oxymetry

2.2

16.5

177

835

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.1

16.5

153

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

16.5

594

4094

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

16.5

141

596

A10BD03

ATC

metformin and rosiglitazone; systemic

2.8

16.5

105

375

G04CA02

ATC

tamsulosin; oral

1.3

16.4

1515

12300

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

16.4

181

866

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

16.4

223

1161

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

16.3

2457

21248

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

16.2

436

2804

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

16.1

329

1960

SPAT1172

SPAT

Guidance concerning hydration

2.3

16.1

148

650

B01AF01

ATC

rivaroxaban; oral

1.5

16.1

680

4842

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

16.0

817

6030

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

16.0

593

4109

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.6

16.0

115

443

A12BA01

ATC

potassium chloride; oral

1.8

16.0

280

1592

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

5.7

15.9

OAB50

SPAT

3.1

15.9

278

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

15.9

896

6732

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.1

15.8

182

886

T82

ICPC

Obesity

2.5

15.8

122

490

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

2.5

15.8

124

501

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

15.8

121

484

C09CA07

ATC

telmisartan; oral

1.7

15.8

369

2288

K99

ICPC

Cardiovascular disease other

2.1

15.8

176

845

SPAT1251

SPAT

Organisation of medication

2.0

15.8

214

1113

R52.9

ICD-10 Finland

Pain, unspecified

1.6

15.7

378

2358

H3603, E113

ICD-10 Finland

3.8

15.7

180

A10BB01

ATC

glibenclamide; oral

1.8

15.7

268

1508

C07BB07

ATC

bisoprolol and thiazides; systemic

1.9

15.7

228

1216

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

15.6

258

1436

L14

ICPC

Leg/thigh symptom/complaint

1.7

15.6

366

2269

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

15.6

282

1622

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.6

15.6

402

2558

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

15.5

216

1130

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

15.5

229

1228

R01AD09

ATC

mometasone; nasal

1.3

15.5

1859

15603

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.6

15.5

110

422

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

15.5

142

624

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

15.5

110

423

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

15.4

298

1747

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.8

15.4

251

1394

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

15.4

392

2485

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.4

15.4

225

M01AB05

ATC

diclofenac; systemic, rectal

1.2

15.3

3291

29589

L15

ICPC

Knee symptom/complaint

1.4

15.3

987

7584

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.1

15.3

170

815

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.3

15.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

15.2

1191

9424

G63.2

ICD-10 Finland

Diabetic polyneuropathy

5.5

15.2

H26.4

ICD-10 Finland

After-cataract

1.5

15.1

545

3754

N06AB06

ATC

sertraline; oral

1.6

15.1

380

2401

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

15.1

1787

14966

N18

ICPC

Paralysis/weakness

2.6

15.1

110

429

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.3

15.1

135

586

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

15.0

505

3423

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

6.6

15.0

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.6

15.0

109

422

WX290

NOMESCO Finland

Other blockade of nerve

1.3

15.0

1629

13490

A98

ICPC

Health maint/preventive medicine

1.4

15.0

5228

49858

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.7

14.9

178

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

14.8

879

6654

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

14.8

586

4114

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

14.8

534

3679

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.1

14.8

172

843

N05CD07

ATC

temazepam; oral

1.4

14.8

696

5056

FXZ00

NOMESCO Finland

Off-pump cardiac operation

4.1

14.7

136

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

14.7

102

387

K74

ICPC

Ischaemic heart dis with angina

3.0

14.7

293

J01MA14

ATC

moxifloxacin; systemic

1.6

14.7

421

2751

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

14.7

225

1222

I20.0

ICD-10 Finland

Unstable angina

3.8

14.7

161

A06AC51

ATC

ispaghula, combinations; systemic

1.8

14.6

239

1329

R03BA05

ATC

fluticasone; inhalant

1.4

14.6

768

5695

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.4

14.6

118

488

M01AE02

ATC

naproxen; oral, rectal

1.2

14.6

2642

23248

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

6.5

14.6

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

14.5

1154

9145

K01

ICPC

Heart pain

2.9

14.5

296

D07AC01

ATC

betamethasone; topical

1.3

14.5

1668

13903

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.7

14.5

102

388

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

14.5

728

5353

I70.0

ICD-10 Finland

Atherosclerosis of aorta

4.7

14.5

102

M01AH02

ATC

rofecoxib; oral

1.4

14.5

688

5011

PD5AD

NOMESCO Finland

CT of aorta

2.6

14.4

103

398

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

3.2

14.3

238

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

14.3

206

1094

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

14.3

232

1288

R03AC03

ATC

terbutaline; inhalant

1.5

14.3

589

4172

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.6

14.3

105

412

E83.51

ICD-10 Finland

Hypocalcemia

27.2

14.2

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.9

14.2

202

1069

B01AC22

ATC

prasugrel; oral

7.1

14.2

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

4.3

14.2

122

A99

ICPC

Disease/condition unspecnature/site

1.6

14.2

392

2536

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

14.2

205

1091

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

5.8

14.1

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

5.5

14.1

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

14.1

150

709

Z00.8

ICD-10 Finland

Other general examinations

1.7

13.9

303

1839

R52.2

ICD-10 Finland

Other chronic pain

2.1

13.9

151

717

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.7

13.9

274

1618

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

13.9

193

1014

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

13.9

139

639

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

4.3

13.9

116

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

13.9

104

414

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

13.8

423

2805

C03BA11

ATC

indapamide; oral

2.1

13.8

164

809

FN1AD

NOMESCO Finland

CT of coronary arteries

3.1

13.8

245

R05FB02

ATC

cough suppressants and expectorants

1.3

13.7

1908

16250

C07AB03

ATC

atenolol; systemic

1.6

13.7

359

2294

R4110

SPAT

2.2

13.7

137

630

C08CA07

ATC

nisoldipine; oral

2.8

13.7

325

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

13.6

505

3496

P03

ICPC

Feeling depressed

1.8

13.6

246

1413

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

4.3

13.6

114

27200

ICD-8 Finland

Congenital disorders of lipid metabolism, Hypercholesterolaemia essentialis sive familiaris

+∞

13.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

13.5

1039

8187

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

4.4

13.5

110

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

4.1

13.5

124

PEQ23

NOMESCO Finland

Insertion of endovascular graft into femoral artery

34.1

13.5

R33

ICD-10 Finland

Retention of urine

1.5

13.5

459

3123

M79.1

ICD-10 Finland

Myalgia

1.5

13.5

499

3455

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

13.5

141

662

WX199

NOMESCO Finland

Other local analgesia

2.1

13.5

152

734

S29

ICPC

Skin symptom/complaint other

1.4

13.4

810

6141

R47.0

ICD-10 Finland

Dysphasia and aphasia

3.4

13.4

195

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.8

13.4

241

1384

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

13.4

298

1823

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

13.4

1576

13151

SPAT1359

SPAT

Use of symptom diary

2.3

13.4

127

570

N03AG01

ATC

valproic acid; systemic, rectal

1.8

13.3

233

1325

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.9

13.3

140

C09DA03

ATC

valsartan and diuretics; oral

1.7

13.3

254

1486

H02AB07

ATC

prednisone; oral

1.4

13.3

686

5066

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

13.3

120

524

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

13.2

198

1069

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

5.7

13.2

N03AX09

ATC

lamotrigine; oral

2.2

13.2

137

640

A02BC04

ATC

rabeprazole; oral

1.6

13.2

346

2207

K59.0

ICD-10 Finland

Constipation

1.7

13.2

274

1644

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.2

13.1

126

569

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

3.4

13.1

188

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

13.1

443

3008

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.8

13.1

E66.0

ICD-10 Finland

Obesity due to excess calories

3.4

13.1

183

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

5.6

13.1

R4120

NOMESCO Finland

Occupational therapy

1.7

13.1

264

1569

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

13.0

190

1016

Z51.88

ICD-10 Finland

Other specified medical care

2.4

13.0

108

454

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

13.0

239

1381

R05

ICD-10 Finland

Cough

1.3

13.0

876

6763

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.2

13.0

206

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

3.5

12.9

169

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

12.9

308

1920

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.7

12.9

A12AA04

ATC

calcium carbonate; oral

2.8

12.9

284

PD1AE

NOMESCO Finland

Ultrasound examination of abdominal aortta

3.5

12.9

170

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.5

12.8

165

K07

ICPC

Swollen ankles/oedema

1.8

12.8

237

1372

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

12.8

283

1729

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.4

12.7

182

PD4AD

NOMESCO Finland

CT of lower extremity arteries

4.7

12.7

A10BJ01

ATC

exenatide; parenteral

4.0

12.7

127

I95.2

ICD-10 Finland

Hypotension due to drugs

3.9

12.6

132

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

12.6

254

S01BC05

ATC

ketorolac; ophthalmic

1.8

12.6

232

1341

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

12.6

204

1131

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

12.6

467

3231

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

12.6

204

1134

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

12.6

261

1565

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.7

12.5

314

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

12.5

442

3028

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

12.5

1171

9474

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

12.5

243

1428

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.2

12.5

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

12.5

100

410

RD211

NOMESCO Finland

1.8

12.5

214

1208

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

12.5

159

810

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

12.5

863

6684

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.5

12.5

164

X58

ICD-10 Finland

Exposure to other specified factors

1.4

12.5

557

4003

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

12.4

128

595

F21

ICPC

3.4

12.4

175

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

12.4

1907

16384

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

12.4

467

3244

M54.3

ICD-10 Finland

Sciatica

1.7

12.4

256

1536

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.0

12.4

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.8

12.3

135

H05BX01

ATC

cinacalcet; oral

5.4

12.3

SPAT1054

SPAT

Examination of peripheral nervous system

2.5

12.3

398

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

6.5

12.3

R06.4

ICD-10 Finland

Hyperventilation

2.9

12.3

248

ZPB22

NOMESCO Finland

Autograft of vein

4.2

12.3

107

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

12.2

1102

8867

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.0

12.2

148

740

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

12.2

761

5800

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

12.1

542

3896

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.0

12.1

152

771

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.5

12.1

163

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

12.1

493

3482

H02AB04

ATC

methylprednisolone; systemic

1.4

12.1

653

4858

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.8

12.1

220

1271

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

12.0

427

2927

SPAT1281

SPAT

Other administrative function

1.5

12.0

377

2517

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

21.3

12.0

WX002

NOMESCO Finland

Sedation and analgesia

1.3

12.0

971

7697

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.2

12.0

118

541

B04AB03

ATC

10.0

12.0

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

11.9

114

513

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

11.9

1142

9260

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.3

11.9

176

U07

ICPC

Urine symptom/complaint other

1.6

11.9

278

1726

PA6AD

NOMESCO Finland

CT of neck arteries

2.9

11.9

254

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

11.9

103

444

A10BX02

ATC

repaglinide; oral

2.7

11.9

287

S22.3

ICD-10 Finland

Fracture of rib

1.6

11.8

322

2078

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

11.8

141

701

R35

ICD-10 Finland

Polyuria

1.6

11.8

331

2150

J45.8

ICD-10 Finland

Mixed asthma

2.0

11.8

140

692

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

11.8

768

5888

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

11.8

277

1723

WVA30

SPAT

2.1

11.7

131

634

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

11.7

1120

9075

N05BA01

ATC

diazepam; systemic, rectal

1.4

11.7

607

4480

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.5

11.7

375

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

11.7

133

649

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

11.6

135

664

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

11.6

146

741

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

11.6

416

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

12.5

11.6

J01FA10

ATC

azithromycin; systemic

1.2

11.6

2389

21130

ACC51

NOMESCO Finland

Release of median nerve

1.6

11.6

294

1864

TK810

NOMESCO Finland

Hemofiltration

4.5

11.6

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.4

11.5

100

429

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

11.5

114

522

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.5

11.5

362

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.8

11.5

258

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

11.5

309

1987

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

11.5

251

1530

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

11.5

1165

9513

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.0

11.5

223

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

6.1

11.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

11.5

2047

17837

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.7

11.4

221

1298

J02AC01

ATC

fluconazole; systemic

1.3

11.4

1445

12117

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

11.4

116

538

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.0

11.4

110

N05AX08

ATC

risperidone; systemic

1.5

11.4

367

2463

N05BA12

ATC

alprazolam; oral

1.5

11.4

422

2921

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.6

11.4

140

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

11.4

364

2443

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.2

11.4

101

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

11.4

139

697

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

11.3

259

1595

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

11.3

256

1575

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

5.0

11.3

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

11.3

962

7670

R06.5

ICD-10 Finland

Mouth breathing

1.5

11.3

372

2511

J01MA01

ATC

ofloxacin; systemic

1.5

11.3

441

3087

M54.8

ICD-10 Finland

Other dorsalgia

1.9

11.2

155

813

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

11.2

1103

8968

H3600, E113

ICD-10 Finland

2.6

11.2

298

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

11.2

405

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.8

11.1

202

1163

-2

ICPC

3.5

11.1

148

P76

ICPC

Depressive disorder

1.9

11.1

168

910

C09DA07

ATC

telmisartan and diuretics; oral

1.8

11.1

204

1182

I63.8

ICD-10 Finland

Other cerebral infarction

3.3

11.1

170

ECB00

NOMESCO Finland

Suture of gingiva

1.9

11.0

164

888

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

11.0

305

1977

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

10.9

293

1886

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.4

10.9

378

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

10.9

129

641

I20

ICD-10 Finland

Angina pectoris

2.5

10.9

342

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

10.9

226

1360

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

10.8

212

1252

R10.0

ICD-10 Finland

Acute abdomen

2.0

10.8

131

657

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.4

10.8

147

U04

ICPC

Incontinence urine

1.7

10.7

230

1397

V03AE02

ATC

sevelamer; oral

6.1

10.7

FM3CN

NOMESCO Finland

Heart perfusion isotope imaging both at rest and with exercise

5.8

10.7

N17

ICPC

Vertigo/dizziness

1.4

10.7

527

3856

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

10.7

136

694

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.4

10.7

148

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

10.6

148

779

G04CA01

ATC

alfuzosin; oral

1.3

10.6

709

5455

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

10.6

133

674

RS222

NOMESCO Finland

2.7

10.6

250

B04AC01

ATC

8.0

10.6

PG2YT

NOMESCO Finland

Implantation of arterial endoprothesis not elsewhere classified

8.0

10.6

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.0

10.5

137

704

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

5.7

10.5

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.6

10.5

295

1922

M01AX05

ATC

glucosamine; oral

1.3

10.5

1117

9170

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

10.4

201

1180

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.7

10.4

235

1444

TAC99

NOMESCO Finland

Other blockade for chronic pain

3.8

10.4

115

E72.0

ICD-10 Finland

Disorders of amino-acid transport

+∞

10.4

R03DC03

ATC

montelukast; oral

1.4

10.4

585

4379

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

10.4

261

1653

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

10.4

162

889

H25.0

ICD-10 Finland

Senile incipient cataract

1.5

10.4

336

2261

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

10.4

160

877

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

10.3

146

775

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.3

10.3

422

XQ800

NOMESCO Finland

Prick test

1.7

10.3

224

1364

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

10.3

144

763

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.3

364

2497

H53.2

ICD-10 Finland

Diplopia

1.9

10.3

141

740

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

10.3

248

1554

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.6

10.2

285

L86

ICPC

Back syndrome with radiating pain

1.6

10.2

233

1439

DAX08

NOMESCO Finland

Fitting of hearing aid

1.6

10.2

249

1564

G45.3

ICD-10 Finland

Amaurosis fugax

2.2

10.2

102

471

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

10.2

260

1653

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.9

10.1

154

837

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

10.1

327

2198

D07AC13

ATC

mometasone; topical

1.2

10.1

1299

10891

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.2

10.1

I47.2

ICD-10 Finland

Ventricular tachycardia

2.1

10.1

118

581

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

7.9

10.1

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

6.9

10.1

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

10.1

367

2537

C10AA06

ATC

cerivastatin; oral

4.3

10.0

XKD00

NOMESCO Finland

Uroflowmetry

1.3

10.0

993

8070

R13

ICD-10 Finland

Dysphagia

1.5

10.0

303

2006

K86

ICPC

Hypertension uncomplicated

1.3

10.0

626

4768

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

10.0

212

1283

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.7

9.9

110

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.1

9.9

105

496

L08

ICPC

Shoulder symptom/complaint

1.3

9.9

872

6982

Z01.7

ICD-10 Finland

Laboratory examination

1.4

9.9

452

3264

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

3.7

9.8

111

L16

ICPC

Ankle symptom/complaint

1.4

9.8

398

2810

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.0

9.8

K08.3

ICD-10 Finland

Retained dental root

1.5

9.8

307

2052

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

8.1

9.8

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

9.8

157

871

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

9.8

1235

10331

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

9.8

619

4723

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.3

9.8

383

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

9.7

257

N03AX14

ATC

levetiracetam; systemic

2.1

9.7

109

530

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

9.7

1004

8201

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.1

9.7

101

475

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.3

9.7

358

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.9

9.7

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

9.7

301

2009

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.3

9.7

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.6

9.7

E78.4

ICD-10 Finland

Other hyperlipidaemia

55.1

9.6

R01AD08

ATC

fluticasone; nasal

1.3

9.6

1112

9205

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

5.3

9.6

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.1

9.6

110

538

H53.4

ICD-10 Finland

Visual field defects

2.1

9.6

106

513

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.2

9.6

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

9.6

161

906

M01AB01

ATC

indometacin; systemic, rectal

1.4

9.6

427

3068

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

9.6

163

923

Z01.3

ICD-10 Finland

Examination of blood pressure

2.6

9.6

271

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.2

9.6

425

A08

ICPC

Swelling

1.7

9.6

200

1206

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

9.6

384

ZXA10

NOMESCO Finland

Bilateral

1.3

9.6

919

7438

G04BD08

ATC

solifenacin; oral

1.5

9.6

345

2379

RD210

NOMESCO Finland

2.5

9.5

290

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

9.5

891

7182

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

9.5

196

1178

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

10.0

9.5

FWW96

NOMESCO Finland

Other reoperation on heart or major thoracic vessels

5.7

9.5

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2.5

9.5

274

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

4.8

9.4

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.4

9.4

131

R06AE07

ATC

cetirizine; oral

1.2

9.4

1778

15507

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

9.4

202

1229

K22

ICPC

Risk factor cardiovascular disease

1.6

9.4

269

1760

E78.3

ICD-10 Finland

Hyperchylomicronaemia

100.2

9.4

WX890

NOMESCO Finland

Intesive care monitoring

3.0

9.4

175

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

9.4

697

5444

R30.0

ICD-10 Finland

Dysuria

1.8

9.4

146

805

N06AX26

ATC

vortioxetine; oral

1.8

9.4

157

885

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.6

9.4

111

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.0

9.3

115

582

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

9.3

130

690

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.0

9.3

108

533

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

9.3

205

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.6

9.3

214

1326

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

9.3

1338

11350

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

9.3

281

1863

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

9.3

775

6159

A10BX09

ATC

[U] dapagliflozin; oral

3.0

9.2

166

S20

ICPC

Corn/callosity

2.1

9.2

100

479

RF220

NOMESCO Finland

2.3

9.2

348

H29

ICPC

Ear symptom/complaint other

1.4

9.2

466

3428

N06AA12

ATC

doxepin; systemic

1.6

9.2

245

1577

P29

ICPC

Psychological sympt/compl other

1.8

9.2

146

808

S76

ICPC

Skin infection other

1.6

9.2

232

1472

M54.1

ICD-10 Finland

Radiculopathy

1.8

9.1

153

862

N01

ICPC

Headache

1.5

9.1

287

1922

C02DE04

ATC

1.8

9.1

157

895

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

9.1

171

998

A05

ICPC

Feeling ill

1.7

9.1

182

1086

SPAT1284

SPAT

Extensive health certificate

2.0

9.1

117

600

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

9.1

273

1810

R00.2

ICD-10 Finland

Palpitations

1.6

9.1

248

1606

L29

ICPC

Musculoskeletal sympt/complt other

1.5

9.0

334

2314

A03

ICPC

Fever

1.4

9.0

503

3761

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

9.0

302

2051

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

9.0

154

875

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

10.0

9.0

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.6

9.0

110

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

9.0

303

2062

N03AF02

ATC

oxcarbazepine; oral

1.9

8.9

122

641

-69

ICPC

Other reason for encounter NEC

1.7

8.9

195

1190

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

8.9

311

2132

U14

ICPC

Kidney symptom/complaint

2.3

8.9

353

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

8.9

406

C09CA02

ATC

eprosartan; oral

2.4

8.9

303

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

8.9

107

538

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

1.9

8.9

120

631

C01AA05

ATC

digoxin; systemic

1.4

8.8

471

3493

RF210

NOMESCO Finland

1.9

8.8

126

675

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

8.8

115

593

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

8.8

147

829

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

8.8

455

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

8.8

953

7820

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

8.8

119

622

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3168

18064

2.43

267.45

4.0

2.9

1802.8

1521.6

ng/l

2.95

2807

15569

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2851

16483

2.27

221.40

2.8

2.0

201.2

232.9

u/l

1.04

2709

15282

(3013826) Glucose [Moles/volume] in Serum or Plasma

4603

32369

2.34

220.71

6.6

4.3

7.2

6.8

mmol/l

28.82

4440

30216

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3469

22015

2.19

210.33

5.8

3.6

68.7

76.8

ng/l

0.15

2810

16613

(3032080) INR in Blood by Coagulation assay

3668

23855

2.18

208.16

12.0

9.9

1.3

inr

0.12

906

6536

(3009343) pH of Capillary blood

973

3489

3.09

202.96

4.3

3.4

7.4

1.27

444

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

979

3549

3.06

200.21

4.3

3.4

5.1

5.2

kpa

0.88

901

3235

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

939

3374

3.07

194.73

4.2

3.3

1.6

1.9

mmol/l

1.79

709

2516

(3020682) Albumin/Creatinine [Ratio] in Urine

2952

18015

2.14

192.75

4.7

3.8

12.1

7.3

mg/mmol

5.46

2015

11137

(3022313) Gas panel - Capillary blood

774

2557

3.29

184.56

4.4

3.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1686

8335

2.37

183.50

28.6

28.9

1.4

1.5

inr

1.71

321

1150

(3009508) Creatinine [Moles/volume] in Urine

2837

17473

2.08

176.43

3.9

3.0

7.1

7.5

mmol/l

5.21

2349

14299

(3012516) Albumin [Mass/volume] in Urine

2791

17097

2.08

176.02

3.9

3.1

295.8

347.0

mg/l

0.28

1925

10750

(3044640) Blood type and Crossmatch panel - Blood

2736

17043

2.02

160.91

3.0

2.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

810

2983

2.95

159.20

4.0

2.6

0.3

e6/l

0.18

794

2924

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3987

28387

1.99

158.74

6.4

6.0

12.0

12.2

umol/l

0.47

3823

26815

(3023368) Bacteria identified in Blood by Culture

2596

16087

2.00

152.97

4.9

4.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2691

16971

1.98

149.98

3.2

2.4

58.3

59.8

u/l

0.55

2551

15504

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3545

24838

1.90

141.22

5.1

4.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

419

1204

3.64

123.00

4.7

3.5

25.8

31.3

mg/l

2.09

308

745

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2385

15249

1.87

120.95

3.3

3.1

36.6

35.1

u/l

0.33

2266

14256

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1285

6636

2.16

119.82

7.9

4.8

1.1

1.0

mmol/l

7.41

1196

6087

(3020779) Urea [Moles/volume] in Serum or Plasma

1012

4766

2.32

118.09

9.2

5.8

11.5

10.3

mmol/l

4.83

953

4499

(3040151) Glucose [Moles/volume] in Capillary blood

281

633

4.59

114.89

19.4

15.8

7.9

7.1

mmol/l

2.58

233

512

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5153

42095

1.96

114.71

8.9

7.2

83.6

80.0

u/l

3.61

4892

39175

(3031040) Bacteria [#/volume] in Urine by Automated count

4594

36334

1.84

111.02

6.6

4.6

1579.7

2398.1

e6/l

0.75

322

500

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1456

8176

2.00

106.91

2.2

1.9

30.3

30.0

0.70

1419

7911

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3762

28254

1.75

106.27

9.4

5.9

1.2

mmol/l

0.23

3289

23485

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1063

5372

2.16

103.41

3.0

2.3

6.7

7.2

ug/l

0.34

901

4627

(3000850) Epithelial cells [#/volume] in Urine

1951

12194

1.85

102.89

3.5

2.5

5.1

4.6

e6/l

1.02

1743

10570

(3015235) Bicarbonate [Moles/volume] in Capillary blood

426

1397

3.19

101.15

3.8

2.8

24.5

25.1

mmol/l

1.76

376

1196

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

580

2257

2.72

101.04

5.0

3.7

24.7

24.9

mmol/l

1.14

532

2050

(3026493) Urate [Moles/volume] in Serum or Plasma

2183

14221

1.79

99.78

3.4

2.7

4236.7

5666.7

umol/l

0.80

1876

11992

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5967

52350

2.25

95.80

24.1

14.8

26.9

26.7

mg/l

0.11

5287

41850

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3252

23895

1.70

95.34

2.3

2.0

95.6

93.4

pmol/l

1.55

1770

12418

(3022948) Iron [Moles/volume] in Serum or Plasma

1453

8440

1.92

95.23

3.3

2.3

11.5

12.6

umol/l

7.22

1350

7710

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

577

2310

2.64

94.82

2.1

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1732

10691

1.84

93.59

5.5

3.6

359.5

550.0

ng/l

1.05

1460

8970

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

611

2533

2.55

93.43

2.2

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

2499

17192

1.72

92.69

4.5

3.2

65.5

106.5

e6/l

1.46

2104

13263

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2141

14148

1.75

91.44

2.5

2.2

3.2

3.1

mg/l

1.71

1843

11910

(3024561) Albumin [Mass/volume] in Serum or Plasma

3264

24178

1.68

91.41

5.6

4.5

34.1

34.9

g/l

10.22

3042

22181

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5693

49284

2.02

91.38

9.3

6.0

44.2

40.2

mmol/mol

131.41

5273

44387

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5649

48789

1.99

91.04

5.9

4.0

1.5

1.3

mmol/l

78.01

5185

43120

(3002030) Lymphocytes/100 leukocytes in Blood

3301

24602

1.67

89.66

6.3

5.9

25.2

26.6

9.65

3036

22530

(3037467) Urinalysis macro (dipstick) panel - Urine

4589

37297

1.73

89.62

5.7

4.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1219

6810

1.97

89.04

3.0

2.4

1.9

1.7

3.60

1085

5962

(3018010) Neutrophils/100 leukocytes in Blood

3251

24208

1.66

88.00

6.0

5.7

59.6

58.2

9.27

3008

22297

(3028626) Oxygen [Partial pressure] in Capillary blood

376

1245

3.14

87.65

2.9

7.8

8.0

kpa

1.98

343

1141

(3013707) Erythrocyte sedimentation rate by Westergren method

4760

39229

1.73

86.71

4.9

4.1

15.9

13.4

mm/h

18.82

4409

35605

(3018095) Leukocytes [#/volume] in Urine

2743

19607

1.67

86.51

5.1

3.6

131.1

114.0

e6/l

0.36

2199

14212

(3006504) Eosinophils/100 leukocytes in Blood

3215

23957

1.66

86.10

6.1

5.8

2.8

2.9

0.47

2984

22010

(3019069) Monocytes/100 leukocytes in Blood

3231

24112

1.65

85.99

6.5

6.1

8.8

8.9

0.99

3010

22229

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1542

9397

1.83

85.76

2.1

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2000

13176

1.74

85.10

3.0

2.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1333

7787

1.89

84.68

3.3

2.2

2.3

g/l

0.46

1235

7108

(3022096) Basophils/100 leukocytes in Blood

3132

23280

1.65

83.97

6.1

5.8

0.6

0.7

4.81

2905

21420

(3013512) EKG study

2491

17505

1.67

82.89

6.0

4.0

—

(3013115) Eosinophils [#/volume] in Blood

3475

26578

1.64

82.59

6.0

5.7

0.2

e9/l

1.44

3106

22991

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3381

25698

1.64

82.28

8.3

5.3

1.2

mmol/l

0.37

3041

22869

(3019309) Folate [Moles/volume] in Red Blood Cells

1846

11998

1.74

81.84

1.9

1.7

1132.7

1165.7

nmol/l

0.82

1470

8802

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

386

1359

2.95

80.75

2.4

2.2

137.9

81.6

ug/min

1.49

260

761

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1256

7305

1.88

80.43

3.4

2.3

20.3

22.3

5.83

1097

6102

(3016502) Oxygen saturation in Arterial blood

1059

5844

1.96

79.35

7.2

6.8

94.6

95.4

3.12

1039

5612

(3013650) Neutrophils [#/volume] in Blood by Automated count

3817

30191

1.61

76.55

8.7

8.6

4.6

4.2

e9/l

13.41

3421

26160

(3003396) Base excess in Arterial blood by calculation

1135

6490

1.90

76.20

6.9

6.5

1.3

1.1

mmol/l

0.83

878

5038

(3006315) Basophils [#/volume] in Blood

3356

25774

1.60

75.84

5.8

5.5

0.0

e9/l

0.01

2968

21981

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2735

20027

1.62

75.18

3.4

2.6

158.6

161.7

ug/l

0.19

2502

18017

(3021901) Oxygen saturation in Capillary blood

314

1025

3.16

74.86

2.9

2.6

—

(3019198) Lymphocytes [#/volume] in Blood

3402

26308

1.59

73.94

5.8

5.5

1.9

e9/l

0.15

3065

22822

(3001604) Monocytes [#/volume] in Blood

3329

25616

1.59

73.87

5.8

5.4

0.7

0.6

e9/l

9.78

2937

21815

(3019150) Specific gravity of Urine by Refractometry

1780

11731

1.70

73.67

5.3

4.3

1.0

kg/l

1.39

354

1759

(3019550) Sodium [Moles/volume] in Serum or Plasma

6141

55626

2.21

72.76

29.4

17.2

139.5

139.7

mmol/l

9.29

6037

54018

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

145

7.34

71.87

1.5

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

145

7.34

71.87

1.5

1.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3855

30815

1.59

71.83

4.1

3.0

68.9

53.1

u/l

8.95

3612

27871

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5757

51033

1.89

71.75

6.4

4.5

4.2

4.6

mmol/l

102.15

5374

45891

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5421

47194

1.77

71.73

5.4

4.4

2.0

2.1

mu/l

0.72

4919

41798

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5638

49660

1.84

71.63

22.2

14.1

71.5

75.2

ml/min/173m2

28.41

4672

40907

(3023103) Potassium [Moles/volume] in Serum or Plasma

6144

55748

2.19

71.08

29.6

17.4

4.0

mmol/l

16.43

6031

54041

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2807

20892

1.59

70.73

2.4

2.1

76.8

79.8

nmol/l

6.43

2458

18087

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5710

50559

1.86

70.38

6.5

4.4

1.3

1.5

mmol/l

116.32

5270

45125

(3022621) pH of Urine by Test strip

722

3618

2.12

70.10

3.5

3.2

—

(3019225) pH of Specimen

1072

6181

1.87

69.57

6.4

3.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

540

2413

2.35

69.43

2.1

1.9

2.5

ug/l

0.00

478

2081

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1860

12581

1.66

68.92

1.8

1.7

43031072.5

29039732.9

pmol/l

0.33

1564

10076

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5864

52445

1.93

68.90

7.0

5.0

2.4

2.7

mmol/l

112.68

5436

46893

(3042936) Bacteria identified in Isolate by Culture

1263

7739

1.78

66.90

2.4

2.0

—

(3026008) Bacteria identified in Urine by Culture

2385

17252

1.59

66.78

3.8

3.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4536

38054

1.59

65.45

4.2

3.7

14.9

15.0

pmol/l

1.45

4077

33539

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1337

8470

1.72

62.48

3.5

3.0

0.8

mmol/l

2.90

1256

7821

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5746

51612

1.78

58.99

6.4

4.8

6.4

6.0

mmol/l

70.69

5215

45673

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

664

3438

2.03

58.58

1.8

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6094

55794

1.99

58.27

14.0

10.4

26.9

25.5

u/l

6.39

5907

53143

(3027801) Oxygen [Partial pressure] in Arterial blood

1075

6527

1.77

57.94

7.2

6.5

11.5

12.0

kpa

2.99

1036

6190

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1075

6530

1.77

57.84

7.3

6.5

5.1

kpa

0.49

1038

6205

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1589

10740

1.63

57.25

1.8

1.6

1.3

1.4

mg/l

0.77

1264

8295

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1182

7442

1.71

55.80

6.3

4.5

33.2

32.9

0.51

857

4783

(3019977) pH of Arterial blood

137

314

4.43

54.76

1.6

2.3

7.4

0.04

138

(3014111) Lactate [Moles/volume] in Serum or Plasma

829

4742

1.85

54.20

6.5

6.1

1.5

1.4

mmol/l

0.84

795

4567

(3014576) Chloride [Moles/volume] in Serum or Plasma

1130

7098

1.71

53.59

7.1

6.3

104.4

104.5

mmol/l

0.26

1031

6963

(3044242) Glucose [Moles/volume] in Arterial blood

123

266

4.69

52.84

1.5

2.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

879

5163

1.81

52.62

3.3

2.8

259.2

227.7

ng/l

0.86

823

4705

(3009261) Glucose [Presence] in Urine by Test strip

3277

26300

1.48

52.43

4.8

3.8

0.0

estimate

1.84

464

4841

(3002032) Base excess in Venous blood by calculation

856

4999

1.82

52.20

4.4

3.4

1.9

mmol/l

0.05

679

4001

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

427

1945

2.28

52.17

2.3

2.2

556.4

602.6

ug/l

0.11

410

1846

(3035350) Ketones [Presence] in Urine by Test strip

3233

25904

1.48

51.99

4.7

3.8

0.0

estimate

0.00

475

4934

(3007853) Bacteria identified in Skin by Aerobe culture

1018

6298

1.73

50.78

2.1

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

3224

25950

1.47

49.84

6.2

5.0

0.0

estimate

0.50

499

4954

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

685

3784

1.90

49.72

5.5

3.3

115.3

90.2

ng/l

5.57

588

3168

(3008152) Bicarbonate [Moles/volume] in Arterial blood

665

3667

1.90

48.47

7.9

6.8

24.7

24.6

mmol/l

0.06

646

3411

(3012544) pH of Venous blood

865

5189

1.77

47.92

4.4

3.4

7.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1899

13865

1.52

47.15

1.7

1.5

18.7

20.3

nmol/l

4.40

1578

11599

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

689

3883

1.86

46.87

1.7

1.6

—

(4146454)

192

619

3.16

46.70

2.9

2.5

—

(3007461) Platelets [#/volume] in Blood

6191

57655

1.94

46.33

35.3

22.0

238.6

240.6

e9/l

1.65

6073

55786

(3024731) MCV [Entitic volume]

6191

57667

1.93

46.12

35.2

21.9

91.6

0.26

6115

56517

(3000963) Hemoglobin [Mass/volume] in Blood

6192

57681

1.94

46.09

35.6

22.1

131.5

134.8

g/l

49.60

6112

56540

(3010813) Leukocytes [#/volume] in Blood

6191

57679

1.93

45.91

35.4

22.0

7.3

6.8

e9/l

22.88

6056

55574

(3026361) Erythrocytes [#/volume] in Blood

6190

57672

1.93

45.81

35.4

22.0

4.4

4.5

e12/l

31.46

6051

55586

(3035941) MCH [Entitic mass]

6189

57666

1.93

45.70

35.2

21.9

30.3

30.5

6.88

6112

56515

(3021447) Carbon dioxide [Partial pressure] in Venous blood

834

5031

1.75

45.14

4.5

3.4

5.8

kpa

0.15

816

4877

(3037121) Protein [Mass/volume] in Urine

401

1893

2.19

44.81

3.9

2.9

0.4

0.3

g/l

2.20

196

754

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

595

3254

1.91

44.33

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

351

1588

2.28

43.49

1.4

1.2

—

(40761511) CBC panel - Blood by Automated count

5860

53904

1.68

42.98

23.3

14.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1816

13353

1.49

42.76

4.4

3.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

861

5322

1.71

42.54

8.1

7.2

119.7

120.9

g/l

0.96

850

5123

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2549

20142

1.43

40.64

5.1

4.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

655

3801

1.80

40.26

2.3

382.1

369.4

nmol/l

0.87

596

3457

(40768797) Stomach Pathology biopsy report

1083

7194

1.60

40.17

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

836

5205

1.69

40.06

2.6

72.4

67.5

e9/l

3.76

692

4006

(3000991) Gas panel - Venous blood

738

4459

1.74

39.43

8.6

7.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

494

2659

1.93

38.47

1.7

1.6

1.7

1.5

g/l

2.71

409

2244

(3027273) Bicarbonate [Moles/volume] in Venous blood

506

2753

1.91

38.14

4.3

3.1

24.9

25.2

mmol/l

0.91

489

2675

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

883

5667

1.64

37.48

3.1

2.6

9.7

9.8

umol/l

0.03

775

4931

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

110

290

3.84

36.53

1.3

1.2

11.6

12.2

mmol/l

0.10

(3049717) Cytology report of Urine Cyto stain

489

2674

1.89

36.25

3.1

2.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

673

4053

1.73

36.24

2.5

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

777

4877

1.67

35.88

2.8

2.4

65.7

66.3

g/l

1.33

716

4331

(42870588) Differential panel, method unspecified - Blood

2268

17901

1.40

34.93

5.9

5.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3030

25165

1.37

33.95

2.5

2.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

787

5031

1.64

33.71

2.2

0.2

g/l

0.11

732

4670

(3024354) Oxygen [Partial pressure] in Venous blood

680

4195

1.69

33.41

3.7

2.9

4.8

4.4

kpa

3.37

666

4049

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

213

879

2.47

32.49

2.2

1.5

0.9

0.8

nmol/l

1.69

173

728

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

381

1997

1.96

32.00

2.9

2.7

0.3

0.4

u/ml

0.06

230

1112

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

980

6714

1.54

31.06

3.6

4.2

244.6

248.0

u/l

0.27

925

6312

(3025468) Yersinia sp identified in Specimen by Organism specific culture

176

682

2.62

30.62

1.4

—

(3019060) Gas panel - Arterial blood

636

3950

1.67

30.35

5.4

4.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

498

2897

1.78

30.10

8.5

8.3

24.3

24.4

mmol/l

0.18

458

2667

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

179

706

2.58

30.05

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

175

684

2.60

29.93

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

175

684

2.60

29.93

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

174

682

2.59

29.59

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

457

2607

1.81

29.49

4.8

3.6

51.2

47.1

2.73

448

2571

(3006184) Hemoglobin [Mass/volume] in Capillary blood

267

1269

2.15

29.27

2.1

2.2

125.5

128.8

g/l

1.23

207

908

(3000034) Microalbumin [Mass/volume] in Urine

137

479

2.90

29.03

3.8

2.7

61.8

31.5

mg/l

0.99

108

340

(3015377) Calcium [Moles/volume] in Serum or Plasma

2350

19081

1.36

28.95

3.2

3.3

2.3

2.4

mmol/l

2.41

1949

16249

(3004809) Band form neutrophils/100 leukocytes in Blood

219

964

2.31

28.94

3.5

3.6

1.5

1.6

0.18

167

738

(3018405) Lactate [Moles/volume] in Arterial blood

391

2142

1.88

28.73

4.7

3.8

1.4

mmol/l

0.34

383

2121

(3024522) Salmonella sp identified in Specimen by Organism specific culture

174

694

2.55

28.56

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1141

8196

1.47

28.55

1.6

1.4

2.6

g/l

0.08

704

4652

(3029937) Albumin [Presence] in Urine by Test strip

1888

14836

1.38

28.52

5.1

4.2

0.0

estimate

1.94

456

4726

(3033658) Prothrombin time (PT) actual/Normal

1707

13205

1.39

28.32

4.6

3.8

85.3

85.4

0.05

1658

12899

(3003181) Sodium [Moles/volume] in Urine

158

608

2.64

27.90

1.3

1.2

65.0

65.7

mmol/l

0.08

134

465

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

680

4396

1.61

27.57

1.9

1.7

1.5

2.68

565

3718

(3023183) Ammonium ion [Moles/volume] in Plasma

219

986

2.26

27.46

2.9

2.4

32.2

34.9

umol/l

0.96

186

811

(3043409) Potassium [Moles/volume] in Arterial blood

346

1853

1.91

27.25

5.1

4.1

3.9

mmol/l

0.75

255

1768

(3005719) IgG [Mass/volume] in Serum or Plasma

561

3486

1.66

26.61

2.9

2.7

10.4

10.7

g/l

0.76

523

3169

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1191

8786

1.43

25.60

3.9

3.0

2.5

2.1

e6/l

0.89

778

4925

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

907

6356

1.49

25.45

1.9

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

236

1131

2.13

25.35

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

205

3.79

25.32

1.2

1.4

1.3

1.5

g/l

—

(3045414) Leukocytes [Presence] in Urine

405

2362

1.76

24.19

2.4

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

156

645

2.45

23.78

3.6

4.3

—

(3000330) Specific gravity of Urine by Test strip

475

2910

1.68

23.74

3.7

3.6

—

(40761535) Cells panel - Urine sediment

751

5143

1.52

23.43

4.2

3.4

—

(3026782) Osmolality of Urine

1435

11081

1.38

23.35

3.5

2.7

540.7

564.5

mosm/kgh2o

4.00

1245

9311

(3028026) IgM [Mass/volume] in Serum or Plasma

444

2695

1.69

22.96

1.8

1.2

1.5

g/l

0.92

403

2410

(3030467) Casts [#/volume] in Urine by Automated count

1960

15903

1.33

22.95

4.3

3.1

0.4

0.5

e6/l

0.89

1571

12104

(3017732) Neutrophils [#/volume] in Blood

548

3516

1.61

22.79

4.1

3.0

4.4

4.2

e9/l

0.78

370

2536

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

178

796

2.27

22.73

2.0

2.1

26.6

28.2

mg/l

0.13

201

(3022145) Colonoscopy Study observation

836

5900

1.48

22.47

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

611

4052

1.56

22.03

1.9

1.5

—

(3014271) Vancomycin [Susceptibility]

335

2.95

21.72

3.2

2.9

—

(3044927) Protein electrophoresis panel - Urine

145

608

2.42

21.48

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

659

4473

1.52

21.36

4.1

2.5

57.5

63.1

ml/min/173m2

3.51

312

1761

(3004119) Hemoglobin [Mass/volume] in Venous blood

519

3340

1.60

21.29

3.6

3.0

125.4

128.2

g/l

1.97

508

3254

(3037756) Immunofixation for Serum or Plasma

243

1260

1.96

21.08

1.4

1.5

—

(40768804) Tissue Pathology biopsy report

2532

21476

1.29

20.82

2.4

2.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

877

6340

1.44

20.68

2.0

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

320

1825

1.79

20.63

3.3

3.0

2.2

2.5

ratio

0.09

118

(3037522) Nuclear Ab [Titer] in Serum

812

5790

1.46

20.59

1.4

1.3

510.8

516.4

titre

0.03

187

1236

(3009445) Proteinase 3 Ab [Units/volume] in Serum

376

2247

1.71

20.59

1.3

1.5

16.4

20.5

u/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

261

3.17

20.56

4.9

2.9

—

(3017181) Myelocytes/100 leukocytes in Blood

667

4602

1.50

19.95

4.3

3.9

0.7

0.9

2.09

252

1330

(36304419) Bacteria [Presence] in Urine

1866

15290

1.31

19.73

4.2

3.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

232

3.26

19.73

1.3

1.2

1.1

1.2

nmol/l

0.28

179

(3032773) Endomysium IgG Ab [Titer] in Serum

322

2.88

19.59

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

164

758

2.19

19.39

6.2

6.4

12.4

11.8

mg/l

0.84

148

691

(3034860) Kappa light chains.free [Mass/volume] in Serum

324

1890

1.75

19.34

3.4

3.0

55.0

57.6

mg/l

0.16

288

1509

(3021440) Promyelocytes/100 leukocytes in Blood

634

4359

1.50

19.27

4.4

3.9

0.1

0.81

241

1224

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

272

3.04

19.20

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

272

3.04

19.20

1.3

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

880

6450

1.42

19.14

3.4

4.1

12.3

24.6

ug/l

1.86

757

5349

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

323

1889

1.75

19.11

3.4

3.0

38.5

46.9

mg/l

0.98

288

1512

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

261

1434

1.85

19.03

1.4

1.5

25.7

18.4

iu/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

304

1752

1.77

18.93

1.4

1.6

235.0

266.3

titre

—

(3034770) Mitochondria Ab [Titer] in Serum

217

1125

1.96

18.87

1.2

840.0

950.0

titre

—

(3014051) Protein [Presence] in Urine by Test strip

226

1191

1.93

18.73

3.0

2.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

359

2177

1.69

18.62

2.7

2.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

216

1131

1.94

18.25

1.2

192.2

157.3

titre

0.17

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

281

2.94

18.16

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

281

2.94

18.16

1.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

281

2.94

18.16

1.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

281

2.94

18.16

1.4

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

255

1414

1.84

18.06

3.5

3.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

185

3.43

18.02

2.6

—

38.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1202

9383

1.34

17.63

1.3

1.2

1.3

1.9

u/ml

1.18

336

2359

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

100

390

2.59

17.34

1.1

—

u/ml

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

361

2238

1.65

17.21

2.3

2.2

7.7

7.4

g/l

2.37

244

1628

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

360

2235

1.65

17.07

2.3

2.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

383

2415

1.62

17.06

4.5

3.6

24.0

24.1

mmol/l

0.22

345

2121

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

253

1426

1.80

17.01

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

359

2233

1.64

16.89

2.3

2.2

3.7

3.8

g/l

0.78

236

1555

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

272

2.89

16.77

2.5

2.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

300

2.79

16.71

2.3

1.8

3.2

2.2

u/field

0.24

187

(3032057) Clostridioides difficile [Presence] in Stool

128

3.85

16.66

2.2

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

358

2.62

16.58

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

133

3.78

16.58

1.6

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

249

1410

1.80

16.49

3.1

0.9

0.8

nmol/l

0.75

188

1087

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

639

4535

1.45

16.47

1.9

1.5

—

(3016750) Collection duration of Urine

316

2.71

16.23

2.0

2.1

487.3

486.8

min

0.02

222

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

12.33

16.02

6.5

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

471

3161

1.53

16.00

2.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

368

2.55

15.70

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1215

9655

1.32

15.53

3.5

2.8

1.2

1.4

e6/l

0.32

800

5747

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2844

25033

1.24

15.49

5.2

5.4

3.3

3.9

ug/l

0.39

2550

22282

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

110

483

2.30

14.81

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

110

483

2.30

14.81

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

110

483

2.30

14.81

1.4

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

939

7237

1.35

14.78

1.3

1.2

13.1

14.0

u/ml

0.07

345

2572

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

437

2942

1.52

14.63

10.2

9.3

—

(3003338) MCHC [Mass/volume]

4510

41829

1.24

14.39

30.1

19.8

330.8

332.0

g/l

15.47

4478

41418

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

357

2307

1.58

14.37

5.1

5.0

1.6

0.80

349

2146

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

557

2.18

14.15

4.5

2.7

—

(3025941) Bacteria identified in Stool by Culture

379

2492

1.55

14.14

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

327

2082

1.60

14.02

2.4

2.2

3.0

3.1

g/l

0.57

238

1592

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

121

3.65

13.96

2.3

2.9

—

(3048689) Calprotectin [Mass/mass] in Stool

680

5024

1.39

13.92

2.0

2.1

201.8

153.0

ug/g

0.69

506

3831

(3000570) Elastase.pancreatic [Mass/mass] in Stool

258

1552

1.69

13.85

1.4

246.2

270.3

ug/g

1.07

150

944

(3011985) Renin [Units/volume] in Plasma

112

512

2.21

13.73

1.4

1.3

133.6

46.5

mu/l

2.10

100

457

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

304

1915

1.62

13.63

1.6

1.7

36.7

38.9

u/l

1.01

249

1643

(3018418) pH of Serum or Plasma

1932

16489

1.24

13.52

5.3

3.6

7.4

1.21

303

3164

(3025159) Blasts/100 leukocytes in Blood

567

4080

1.43

13.50

4.3

4.0

0.4

0.3

0.16

200

1035

(3036489) Thrombin time

274

1687

1.65

13.47

2.0

21.5

21.7

0.16

237

1496

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

2097

1.58

13.19

2.2

9.7

10.5

g/l

1.85

268

1716

(3047181) Lactate [Moles/volume] in Blood

269

1659

1.65

13.14

5.9

6.0

1.4

1.3

mmol/l

1.06

249

1454

(40760892) CBC W Ordered Manual Differential panel - Blood

1292

10562

1.28

13.05

4.8

4.5

—

(3004775) Volume in Urine collected for unspecified duration

102

459

2.24

13.01

2.5

2.2

659.7

630.4

0.21

287

(40768446) Kidney Pathology biopsy report

138

3.35

12.83

1.6

—

(3000494) Fungus identified in Specimen by Culture

791

6084

1.34

12.51

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

967

7669

1.30

12.30

1.3

39.1

40.0

iu/ml

0.05

277

2325

(46235355) HIV 1 and 2 tests - Meaningful Use set

690

5219

1.36

12.18

1.9

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

299

2.49

12.06

1.7

1.2

1.5

1.3

promille

0.50

228

(3051593) INR in Capillary blood by Coagulation assay

330

2.41

11.99

10.9

13.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

108

515

2.12

11.96

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

231

1406

1.67

11.91

1.5

1.6

13832.8

16154.3

e6/l

0.23

164

1016

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

332

2.40

11.83

1.2

2.1

mmol/l

0.02

314

(3042733) HLA Ab [Presence] in Serum

3.73

11.80

6.5

4.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

376

2582

1.48

11.46

2.8

2.4

0.7

0.10

365

2445

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

124

633

1.98

11.43

1.1

7.4

71.8

iu/ml

2.96

136

(3007930) Methemoglobin/Hemoglobin.total in Blood

339

2283

1.51

11.36

5.2

5.0

0.9

0.28

333

2124

(3020876) Protein [Mass/time] in 24 hour Urine

447

2.16

11.32

1.7

1.8

0.7

1.3

g/24h

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

383

2.26

11.30

1.2

2.4

2.9

u/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

363

2484

1.49

11.26

1.2

1.3

193.4

276.3

u/ml

1.45

338

2266

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

254

1607

1.60

11.24

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

223

1368

1.65

11.18

2.4

3.7

3.6

g/l

0.62

212

1298

(3038026) Centromere Ab [Units/volume] in Serum

417

2.20

11.17

1.2

30.2

64.8

u/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

346

2350

1.50

11.14

3.2

3.0

4.3

4.4

pmol/l

0.64

298

2032

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

407

2.20

10.99

1.2

43.6

41.1

u/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

105

515

2.06

10.84

2.4

2.1

2.2

1.7

u/field

0.50

156

(40758558) Short blood count panel - Blood

1544

13132

1.23

10.72

6.9

6.5

—

(3045424) Erythrocytes [Presence] in Urine

159

900

1.79

10.68

1.6

1.4

—

(3020491) Glucose [Moles/volume] in Blood

361

2.26

10.65

1.6

2.1

7.6

6.9

mmol/l

1.08

242

(3004616) Nuclear Ab [Presence] in Serum

115

592

1.96

10.39

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

121

3.24

10.37

1.5

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

101

498

2.04

10.30

1.3

286.6

262.1

pmol/l

0.27

384

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

263

2.45

10.13

1.2

1.1

129.2

90.3

u/l

0.86

200

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

263

2.45

10.13

1.2

1.1

54.7

29.3

u/l

0.73

196

(3017354) Segmented neutrophils/100 leukocytes in Blood

120

633

1.91

10.11

3.0

3.7

64.9

57.6

2.57

404

(3009466) Valproate [Moles/volume] in Serum or Plasma

116

606

1.93

10.06

4.9

4.3

357.6

348.7

umol/l

0.30

502

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

132

722

1.84

9.95

3.5

2.5

374.6

2049.0

u/ml

1.21

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

193

1178

1.66

9.91

1.3

1.2

7.6

41.4

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

204

1264

1.63

9.88

1.9

1.5

0.3

0.2

g/l

2.45

194

1196

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

209

1309

1.62

9.69

1.9

1.5

1.2

g/l

1.67

198

1239

(3052851) Hemolysis interference index of Serum or Plasma

244

1587

1.56

9.65

3.7

3.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

138

773

1.80

9.64

1.2

1.3

—

(1616796) Gas panel - Central venous blood

195

1209

1.63

9.43

3.4

3.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

181

1110

1.65

9.16

1.3

628.1

583.0

mg/l

0.34

172

1051

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

103

536

1.94

9.08

1.4

1.3

—

nmol/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

278

1887

1.49

9.03

2.7

2.3

1.0

1.2

g/l

0.36

234

1573

(40761536) Microorganisms panel - Urine sediment

339

4723

0.70

9.01

5.3

3.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

569

1.89

8.85

1.5

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

231

2.44

8.84

1.5

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

231

2.44

8.84

1.5

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

179

1107

1.63

8.78

1.3

1.2

2.3

2.7

u/ml

0.16

106

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

419

2.04

8.74

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

597

4643

1.31

8.68

3.1

2.4

37.7

64.4

u/l

0.83

494

3975

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

510

1.94

8.66

1.2

63.1

65.6

u/l

0.09

328

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

180

1119

1.63

8.65

1.3

1.2

9.3

4.6

u/ml

0.30

177

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

103

546

1.90

8.61

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

106

568

1.88

8.58

1.7

1.9

—

(3006270) Folate [Moles/volume] in Blood

487

1.94

8.42

1.3

1.2

304.7

336.4

nmol/l

0.72

381

(1761482) Bacteria [#/volume] in Urine by Culture

242

1622

1.51

8.38

3.9

4.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

189

2.55

8.37

3.6

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

178

1113

1.62

8.37

1.5

1.6

—

(3024928) Oxygen saturation in Venous blood

166

1023

1.64

8.28

3.1

2.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

328

2.15

8.24

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

233

2.37

8.22

1.5

2.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

429

1.99

8.22

1.8

1.5

—

1422.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

284

2.23

8.16

1.0

291.9

283.9

mg/l

0.38

248

(3035637) Corticotropin [Mass/volume] in Plasma

100

535

1.88

8.16

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

109

600

1.83

8.13

1.1

1.6

1.5

g/l

0.64

534

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

109

600

1.83

8.13

1.4

1.3

0.7

nmol/l

0.18

104

578

(3016038) Potassium [Moles/volume] in Urine

204

2.46

8.11

1.1

1.2

32.6

36.8

mmol/l

0.69

164

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

108

3.07

8.10

1.2

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

542

4204

1.31

8.03

4.3

3.8

0.6

0.7

0.41

149

966

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

148

2.71

7.90

1.7

2.0

59.4

120.2

umol/l

1.07

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

535

1.86

7.84

1.5

1.7

—

(3002256) Pathology report gross observation

879

7264

1.24

7.79

1.4

1.3

—

(3017509) Phencyclidine [Presence] in Urine

6.20

7.70

2.1

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

108

604

1.80

7.68

1.4

1.3

0.1

0.3

nmol/l

1.38

(3003434) Protein [Mass/volume] in Pleural fluid

146

889

1.66

7.66

1.7

1.4

31.3

32.4

g/l

0.46

138

791

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

434

1.95

7.63

1.3

1.2

1.6

1.4

nmol/l

0.74

385

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

252

1739

1.47

7.60

2.4

2.1

37.2

37.4

g/l

0.13

206

1436

(3042631) Mycobacterium sp identified in Specimen

146

895

1.65

7.48

2.5

2.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

153

950

1.62

7.45

7.7

4.4

667.3

2168.9

iu/ml

0.44

136

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

151

935

1.63

7.43

1.3

1.2

1.9

5.8

u/ml

0.96

(44816559) Phosphatidylethanol [Mass/volume] in Blood

117

679

1.74

7.35

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

117

682

1.73

7.24

1.7

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

107

608

1.77

7.24

1.4

1.3

295.9

507.2

u/l

0.99

101

570

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

235

1618

1.47

7.19

2.5

2.1

0.1

g/l

0.03

214

1450

(3024980) IgG subclass 4 [Mass/volume] in Serum

120

707

1.71

7.15

1.8

1.6

0.7

0.9

g/l

1.36

527

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.09

6.99

1.7

1.3

188.4

125.9

ng/l

0.56

(3028433) Virus identified in Specimen by Culture

182

2.43

6.98

1.1

—

(1761868) Lipid panel - Serum or Plasma

1707

15146

1.17

6.98

4.1

3.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

141

874

1.63

6.94

1.4

10.3

10.1

u/l

0.06

116

715

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

214

2.30

6.90

1.4

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

105

1765

0.59

6.83

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

402

1.93

6.83

1.3

279.6

284.1

mosm/kgh2o

0.86

291

(3017704) Immunofixation for Urine

294

2.08

6.76

1.3

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

190

2786

0.67

6.72

1.9

1.8

—

(3024471) HLA-A [Type]

111

2.80

6.56

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

194

1311

1.49

6.55

1.5

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

186

1248

1.50

6.50

3.3

1.8

1.6

mg/l

2.73

165

1114

(3035880) pH of Pleural fluid

340

1.98

6.47

1.4

1.3

—

(3024932) HLA-DR beta [Type]

107

2.81

6.40

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

183

1229

1.50

6.38

1.7

1.8

12.2

11.6

mg/l

0.35

168

1130

(3044889) 12 lead EKG panel

4052

38364

1.14

6.37

4.9

4.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

121

741

1.64

6.29

1.3

1.5

59.5

60.8

0.13

477

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

353

1.94

6.17

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

156

2.44

6.17

2.1

67.8

58.1

umol/l

0.91

122

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

194

1332

1.47

6.08

2.1

2.2

87.9

88.7

0.15

175

1268

(3051651) Icteric interference index of Serum or Plasma

301

2.00

6.01

3.5

2.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

221

2.18

6.01

1.3

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

128

808

1.60

5.91

3.9

2.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

580

1.70

5.83

1.4

1.3

64280.4

175968.5

e6/l

1.81

398

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.82

5.82

1.1

1.2

0.8

0.7

umol/24h

0.50

(3011397) Hemoglobin [Presence] in Urine by Test strip

1427

12648

1.16

5.78

4.7

3.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

143

932

1.55

5.77

1.6

1.5

5.3

4.1

iu/l

0.36

283

(3023199) Leukocytes [#/volume] in Pleural fluid

126

800

1.59

5.70

1.7

1.5

1513.1

2079.1

e6/l

0.96

107

578

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

128

816

1.58

5.69

1.8

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

232

1669

1.40

5.68

2.0

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

342

2616

1.32

5.67

1.4

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

195

1360

1.45

5.66

2.8

3.3

1705.2

830.0

u/ml

0.31

174

1241

(3010503) CD19 cells [#/volume] in Blood

308

1.96

5.66

2.5

2.2

0.4

0.2

e9/l

0.47

298

(21494755) Public health laboratory ask at order entry panel

162

2363

0.68

5.63

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

459

1.77

5.63

1.6

1.4

6.6

7.1

g/l

0.49

315

(3019230) Fractional oxyhemoglobin in Venous blood

133

858

1.56

5.62

2.5

66.1

63.5

0.69

133

853

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.40

5.57

4.7

2.1

0.8

0.3

u/field

1.01

(4094501)

197

1382

1.44

5.55

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

187

1300

1.45

5.53

1.7

—

(4062490)

454

1.77

5.53

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

116

728

1.60

5.52

1.4

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

244

2.06

5.44

1.4

1.8

12.7

10.9

umol/l

0.14

176

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

143

947

1.52

5.39

1.3

1.4

29.1

18.2

e6/l

0.38

118

755

(3028192) IgG subclass 2 [Mass/volume] in Serum

459

1.75

5.35

1.6

1.4

2.5

2.9

g/l

1.65

316

(3024139) IgG subclass 3 [Mass/volume] in Serum

459

1.75

5.35

1.6

1.4

0.4

g/l

0.68

315

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

143

949

1.52

5.34

1.4

1.5

1189.9

935.0

e6/l

0.12

126

791

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

308

1.92

5.32

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

304

1.92

5.18

1.4

30.8

29.4

u/l

0.10

253

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

990

1.50

5.14

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

193

1372

1.42

5.09

2.1

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

174

1217

1.44

5.03

2.5

212.6

202.0

0.74

161

1156

(3028308) Erythrocytes [#/volume] in Pleural fluid

115

738

1.57

5.02

1.6

1.4

107840.7

60968.6

e6/l

0.41

433

(3026389) Candida sp identified in Specimen by Organism specific culture

109

691

1.59

5.01

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

388

3072

1.28

5.00

2.5

32.5

25.2

au/ml

—

114

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

278

2108

1.33

4.94

2.8

3.5

638.8

1478.0

u/ml

0.76

248

1801

(21494815) CD4 cells/100 lymphocytes in Specimen

367

1.81

4.93

2.3

2.1

42.0

42.6

—

(3023419) Bacteria identified in Sputum by Culture

116

750

1.56

4.91

2.8

2.4

—

(3044290) Cell count panel - Cerebral spinal fluid

129

854

1.52

4.91

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

105

665

1.59

4.86

1.4

1.2

266.5

283.7

u/ml

0.23

397

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

171

1202

1.43

4.82

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

171

1202

1.43

4.82

1.4

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

305

1.88

4.81

2.4

2.2

236.4

64.9

ug/min

0.69

(3016018) Differential panel - Cerebral spinal fluid

430

1.73

4.78

1.3

1.4

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

5.01

4.77

1.7

1.2

0.6

1.0

u/field

—

(3001729) Color of Synovial fluid

3.16

4.75

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.95

4.70

1.1

—

6.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

224

2.02

4.69

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

2.01

4.64

1.1

—

(3011412) CD3 cells [#/volume] in Blood

465

1.69

4.60

2.3

2.2

1.3

1.1

e9/l

0.45

283

(3010375) cycloSPORINE [Mass/volume] in Blood

186

2.10

4.56

35.3

25.9

119.6

114.9

ug/l

0.11

161

(3020891) Body temperature

317

2482

1.29

4.50

6.7

4.3

—

(3041354) Potassium [Moles/volume] in Venous blood

116

768

1.52

4.45

2.3

4.1

mmol/l

0.88

116

760

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

485

1.66

4.45

1.4

1.7

22.2

28.7

u/ml

0.31

104

(4015189)

188

2.08

4.44

2.4

2.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

336

1.79

4.42

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

112

2.42

4.37

1.1

—

(4211845)

294

1.84

4.36

4.6

3.6

—

(3028707) Methadone [Presence] in Urine by Screen method

274

1.87

4.29

2.8

2.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

107

2.44

4.29

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

498

1.63

4.28

1.2

7.7

7.8

mmol/l

0.12

350

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

904

7910

1.17

4.26

9.6

7.4

—

(3035285) Chloride [Moles/volume] in Venous blood

115

768

1.51

4.26

2.3

105.7

105.9

mmol/l

0.16

115

760

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

355

1.75

4.25

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2173

20137

1.12

4.24

4.6

4.7

22.8

21.9

1.67

1078

10895

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

249

1.89

4.14

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

126

863

1.47

4.13

1.3

—

(4010399)

479

3977

1.22

4.10

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

575

1.57

4.08

3.4

2.7

—

(3011648) Oxygen content in Venous blood

345

1.75

4.07

2.4

11.5

10.8

0.67

345

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

116

2.33

4.07

1.5

0.4

ug/l

0.10

(4035726)

585

4956

1.20

4.06

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

316

1.78

4.05

3.5

4.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

302

1.79

4.03

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

112

755

1.49

3.99

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

340

1.74

3.98

2.2

2.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

125

2.25

3.89

1.4

1.3

—

(3024263) Appearance of Synovial fluid

306

1.77

3.87

1.7

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

400

3283

1.23

3.85

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.77

3.84

1.1

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1522

1.34

3.83

2.5

2.2

0.0

g/l

1.04

182

1357

(3030313) Adrenal Ab [Titer] in Serum

6.01

3.81

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

146

2.13

3.79

1.9

2.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

132

929

1.43

3.79

1.2

1.3

36.4

39.9

u/l

0.15

117

806

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

346

1.71

3.77

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

555

1.56

3.76

1.1

—

(3048879) Bone marrow aspiration report

194

1.96

3.76

1.3

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

438

1.63

3.75

1.2

1.1

—

3.5

—

(40768441) Liver Pathology biopsy report

339

1.72

3.75

1.4

1.3

—

(3006462) Nitrate [Presence] in Urine

273

1.80

3.73

4.9

3.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

118

817

1.45

3.70

1.7

1.4

25.3

18.1

u/ml

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

333

1.72

3.70

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

234

1812

1.30

3.67

1.7

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

253

1980

1.29

3.67

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

103

696

1.49

3.66

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

253

1.82

3.65

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

112

770

1.46

3.65

1.8

1.6

301.4

293.9

mu/l

0.08

107

710

(36660697) Celiac disease serology panel - Serum

407

3371

1.22

3.60

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

123

2.20

3.59

2.5

2.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

322

1.71

3.55

1.6

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

3.85

3.52

1.1

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

415

1.62

3.51

1.4

1.3

45.6

79.4

titre

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

118

2.21

3.50

1.7

1.4

12.9

16.5

pmol/l

2.80

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

10.01

3.49

8.5

6.2

1.8

2.4

g/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

196

1493

1.32

3.48

2.5

2.2

0.0

g/l

0.00

181

1353

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

393

1.63

3.47

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

193

1.92

3.47

1.3

190.3

486.1

ug/l

0.56

108

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

115

805

1.44

3.43

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

426

1.60

3.41

1.4

1.3

526.0

337.8

titre

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

267

1.77

3.38

1.0

1.1

4.4

12.7

nmol/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

209

1614

1.30

3.38

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

202

1.89

3.38

1.6

1.5

—

(4198724)

2.44

3.37

2.3

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.50

3.37

1.3

1.2

—

(3004451) EKG impression Narrative

246

1.79

3.34

1.5

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

154

2.02

3.34

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

161

1.99

3.33

2.8

31.2

28.4

umol/l

0.84

128

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.72

3.31

4.9

4.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

314

1.69

3.31

1.7

2.4

486.7

500.1

e6/l

0.05

263

(40768806) Pleura Pathology biopsy report

101

696

1.46

3.29

1.8

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

197

1.88

3.28

1.5

1.8

6603.0

15848.4

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

315

1.69

3.27

1.4

1.6

3.5

7.3

u/l

1.37

142

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

248

1.78

3.26

1.3

1.5

12.9

6.2

u/l

0.63

203

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.03

3.24

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

316

1.68

3.24

1.8

2.4

543.3

562.1

e6/l

0.09

140

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

184

1.91

3.23

2.9

2.6

—

(3000764) Benzodiazepines [Presence] in Urine

601

1.49

3.22

2.1

1.7

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.96

3.13

1.5

2.5

62.6

58.5

—

(3014891) Appearance of Pleural fluid

2.47

3.12

1.9

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

131

2.07

3.11

1.1

—

(3036603) Volume of Urine

282

1.71

3.11

1.4

1.8

1812.7

1817.0

0.01

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

144

1068

1.36

3.10

1.0

1.1

16.4

9.3

u/ml

—

(3052592) Norovirus Ag [Presence] in Stool

118

2.12

3.09

1.4

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

246

1.75

3.06

1.4

2.2

15.7

17.2

nmol/l

0.50

232

(3006922) Hepatitis E virus Ab [Presence] in Serum

261

1.73

3.05

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

217

1.80

3.04

1.1

ratio

—

(3016879) Cocaine [Presence] in Urine

568

1.48

3.04

2.2

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.58

3.04

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

142

1056

1.35

3.02

1.3

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

570

1.48

2.99

1.6

1.5

31.5

28.2

0.32

363

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.54

2.95

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

115

830

1.39

2.95

1.1

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

134

2.02

2.95

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

257

1.72

2.93

1.3

1.2

226.6

441.4

u/l

1.14

241

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

298

2450

1.23

2.90

1.2

116.4

126.3

iu/ml

0.19

120

859

(3027008) Opiates [Presence] in Urine

608

1.45

2.88

2.1

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.23

2.79

1.8

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

194

1.81

2.79

2.0

1147.3

3165.5

e6/l

0.37

136

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.47

2.78

2.1

2.2

—

(3027944) Amphetamines [Presence] in Urine

597

1.45

2.76

2.1

1.6

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.34

2.75

9.0

5.5

346.6

437.5

umol/l

—

(3003694) ABO and Rh group [Type] in Blood

1453

13457

1.10

2.70

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.43

2.70

2.1

2.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

6.00

2.69

1.8

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

2.69

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.33

2.64

1.1

18.2

18.5

u/l

0.03

(3028300) Cannabinoids [Presence] in Urine

611

1.43

2.64

2.2

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.21

2.63

1.2

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

169

1.84

2.62

1.8

18327.0

19904.8

e6/l

0.04

(4306422)

546

1.45

2.61

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.67

2.59

1.7

1.5

18.8

16.5

nmol/l

—

(40768443) Skin Pathology biopsy report

307

2564

1.21

2.59

1.3

1.2

—

(4024509)

581

1.43

2.57

1.8

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

331

2791

1.20

2.53

1.3

33.3

58.2

au/ml

—

123

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.50

2.52

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

136

1.92

2.49

1.3

1.1

1428.7

1571.0

miu/ml

0.29

136

(4281824)

486

1.47

2.48

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

165

1.82

2.48

1.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.11

2.48

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

202

1.74

2.47

2.7

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1113

0.71

2.47

1.6

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.38

2.47

1.0

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

166

1304

1.28

2.46

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

170

1340

1.28

2.45

1.7

1.6

20.9

6.8

iu/ml

0.30

302

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.67

2.44

1.2

2.2

1.9

umol/24h

0.22

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

188

1.76

2.44

9.1

5.8

69.3

71.9

0.21

150

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.55

2.44

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.24

2.43

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

288

1.60

2.41

2.0

2.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

244

2009

1.22

2.40

3.9

116.5

91.7

u/ml

0.17

238

1931

(3036670) Protein [Mass/volume] in Synovial fluid

204

1.72

2.40

1.2

41.4

40.7

g/l

0.10

111

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

167

1.80

2.40

3.1

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

507

1.44

2.38

1.1

0.6

2.0

u/ml

1.88

212

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.35

2.38

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

166

1310

1.27

2.38

1.7

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

153

1.83

2.37

1.0

1.1

101.0

93.7

0.96

116

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

679

6078

1.13

2.36

4.0

3.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

1.92

2.35

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

147

1145

1.29

2.34

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

134

1031

1.31

2.34

1.4

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.18

2.30

2.9

2.6

—

(3016228) CD19 cells/100 cells in Blood

207

1.69

2.29

2.8

1.8

11.3

7.7

0.56

202

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

177

1.75

2.29

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

587

1.40

2.28

3.6

3.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

723

1.36

2.28

1.8

1.4

111.8

126.3

u/ml

0.56

167

(3026726) Creatinine [Moles/volume] in Specimen

2.69

2.27

3.2

1.9

556.3

654.3

umol/l

0.07

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

178

1.75

2.25

1.1

u/l

0.09

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

1.97

2.20

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.41

2.19

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

336

1.52

2.18

2.6

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.13

2.18

1.1

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

161

1282

1.26

2.17

1.6

—

(3047189) Immunofixation for 24 hour Urine

257

1.60

2.17

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

4273

41598

1.07

2.16

28.1

18.0

14.1

13.8

25.48

4219

40488

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.30

2.14

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

469

1.43

2.13

2.1

1.7

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.37

2.12

1.2

1.1

18.6

18.8

g/l

0.03

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

416

4748

0.87

2.10

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

149

1182

1.27

2.09

1.8

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

1.98

2.05

1.1

1.2

99.9

54.2

mu/l

0.31

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

103

1.94

2.04

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

130

1018

1.28

2.03

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

359

1.48

2.01

2.3

2.0

15.8

15.7

0.01

148

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

104

793

1.32

1.99

1.3

1.2

52.4

43.8

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

681

1.34

1.98

1.2

1.3

202.4

216.1

miu/ml

0.11

237

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

3.75

1.93

1.0

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

1.76

1.92

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.05

1.90

1.1

1.2

43.3

54.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

423

1.42

1.88

1.0

1.1

1.0

1.3

u/ml

0.17

196

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.18

1.88

1.3

1.7

—

(3007916) DNA double strand Ab [Titer] in Serum

2.31

1.87

1.1

1.2

—

102.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.65

1.86

1.1

—

mmol/l

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

129

1.79

1.85

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

129

1.79

1.85

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

129

1.79

1.85

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

129

1.79

1.85

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

214

1.59

1.81

3.5

3.3

79.4

67.9

mg/l

0.30

143

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

238

1.56

1.81

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

377

1.44

1.79

1.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

128

1019

1.26

1.79

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

176

1.65

1.78

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

287

1.50

1.78

2.5

1.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.50

1.73

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

132

1.74

1.73

1.2

1.1

—

(3008898) HLA-B27 [Presence]

132

1060

1.25

1.73

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.70

0.0

1.1

—

48.8

—

(3012441) Differential panel - Pleural fluid

684

1.31

1.66

1.7

1.5

—

(40758358) Immune stain study

3.16

1.66

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.16

1.66

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.16

1.66

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.16

1.66

5.3

3.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.10

1.65

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

244

1.52

1.64

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

123

987

1.25

1.64

1.6

—

(3011288) Drugs identified in Urine by Screen method

394

1.40

1.61

2.7

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

143

1.68

1.60

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.69

1.58

1.3

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

121

1.74

1.58

1.5

1.6

10.2

9.3

ug/l

0.33

121

(3045716) Anion gap in Serum or Plasma

255

1.49

1.57

2.0

2.5

8.9

9.0

mmol/l

0.07

194

(3003888) Timothy IgE Ab [Units/volume] in Serum

439

1.37

1.57

1.0

1.1

4.1

4.8

u/ml

0.18

224

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

682

1.29

1.56

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

166

1383

1.21

1.56

1.2

—

(40768800) Prostate Pathology biopsy report

144

1743

0.82

1.55

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

248

1.49

1.54

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

684

1.29

1.53

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

216

1846

1.18

1.53

1.2

—

(21494434) Karyotype in Bone marrow

527

1.33

1.53

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.27

1.53

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

166

1387

1.20

1.52

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.59

1.51

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.86

1.50

2.5

1.4

4.5

4.7

nmol/l

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.95

1.48

1.1

1.2

7.4

6.9

mmol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

565

1.31

1.48

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.43

1.47

1.1

18.2

10.7

u/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

125

1019

1.23

1.47

1.4

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

284

1.45

1.47

1.1

1.2

98.9

91.7

u/l

0.20

239

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

140

1.65

1.44

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

1.79

1.42

2.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

800

1.25

1.41

1.5

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

246

1.47

1.39

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

246

1.47

1.39

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

519

1.31

1.38

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

339

1.39

1.37

1.7

2.1

89.0

43.8

umol/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.14

1.33

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

978

1.22

1.33

1.4

—

(44806118)

558

1.29

1.32

1.7

1.4

—

(44790047)

558

1.29

1.32

1.7

1.4

—

(44790049)

558

1.29

1.32

1.7

1.4

—

(44790048)

558

1.29

1.32

1.7

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

241

1.45

1.32

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

445

1.33

1.31

1.5

1.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.81

1.31

1.3

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.50

1.30

1.0

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.09

1.30

1.7

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.09

1.30

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

162

1378

1.18

1.27

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.22

1.24

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1197

0.82

1.22

1.5

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

199

2286

0.87

1.22

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.04

1.22

1.4

1.8

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

189

1635

1.16

1.21

1.2

0.7

1.0

u/ml

0.29

147

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

116

1.64

1.21

1.8

1.2

136.4

44.6

mg/l

0.28

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.72

1.21

1.9

1.4

5.6

10.8

—

(3020650) Glucose [Presence] in Urine

143

0.49

1.20

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

109

1.65

1.18

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

534

1.28

1.16

1.2

1.1

126.8

114.6

2.14

479

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

1.16

1.7

46.5

45.7

umol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

102

1.67

1.16

7.8

7.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

126

1.59

1.14

7.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

126

1.59

1.14

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

199

1.46

1.14

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

206

1804

1.15

1.14

1.7

—

(3021589) Normoblasts [#/volume] in Blood

2379

23064

1.05

1.11

12.0

9.6

0.0

e9/l

0.33

2005

18908

(40767503) Oxygen content in Capillary blood by calculation

141

1203

1.18

1.10

2.8

2.3

15.7

16.1

0.58

608

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.26

1.10

1.0

—

(3045788) Cell count panel - Pleural fluid

610

1.25

1.10

1.7

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.67

1.10

1.4

3.3

—

(3045142) Bone marrow Pathology biopsy report

638

1.24

1.09

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

801

1.21

1.08

1.8

1.5

254.9

210.5

pmol/l

0.31

779

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

252

1.39

1.08

1.1

345.6

307.0

mg/l

0.47

220

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

181

0.55

1.08

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

210

1.43

1.08

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

350

0.68

1.06

1.3

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

203

1.43

1.05

1.1

65.5

707.6

ng/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.96

1.03

1.0

1.5

—

(40762814) Titanium [Mass/volume] in Blood

130

1.54

1.02

1.7

2.2

2.6

3.8

ug/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

359

1.31

1.01

1.1

1.2

68.0

130.7

titre

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

528

4905

1.08

1.00

1.6

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

107

1.59

0.99

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

619

1.23

0.99

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

440

1.28

0.99

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

370

1.30

0.98

2.2

—

(4027681)

181

1.44

0.98

1.1

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

46.6

—

(44806071)

1.80

0.96

1.1

—

(3018133) Calcium [Moles/volume] in Urine

1.77

0.94

1.0

1.6

3.3

2.5

mmol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.77

0.94

2.1

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

242

1.37

0.94

1.5

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

125

1.52

0.93

2.3

2.6

13.2

7.2

mmol/l

1.29

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.61

0.93

1.1

1.6

10.1

9.0

mmol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

257

0.66

0.93

1.2

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1433

13786

1.05

0.92

1.7

1.6

1.3

mmol/l

14.55

1231

11175

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

350

0.71

0.91

1.3

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

818

1.19

0.91

1.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

288

1.32

0.89

1.2

1.5

0.2

nmol/l

0.12

223

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.79

0.87

9.5

5.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

100

851

1.18

0.86

1.1

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1063

0.84

0.86

3.8

3.7

59.7

58.3

0.60

1063

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

204

1.37

0.85

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

113

973

1.16

0.84

2.1

1.8

183.9

203.7

pmol/l

1.43

102

908

(3000492) Spirometry study

458

4267

1.08

0.84

1.6

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.94

0.84

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.78

0.84

1.4

1.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

292

1.30

0.82

1.3

1.5

4.6

4.0

0.10

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

427

1.24

0.80

1.0

649.8

714.4

ng/l

0.64

269

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

236

0.68

0.80

1.3

1.4

—

(3019174) dRVVT (LA screen)

1.82

0.79

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

235

0.68

0.78

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

235

0.68

0.78

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

235

0.68

0.78

1.2

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

429

1.24

0.78

1.0

39.3

48.1

ng/l

0.75

276

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

429

1.24

0.78

1.0

271.7

350.7

ng/l

1.55

281

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.59

0.78

7.5

7.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.51

0.77

1.0

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

122

0.57

0.77

4.3

6.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

648

1.19

0.77

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

591

5583

1.06

0.75

1.4

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.52

0.75

2.4

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

288

1.29

0.75

1.0

1.1

1.9

2.4

u/ml

0.16

108

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.57

0.74

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.60

0.74

1.1

1.3

39.7

1276.6

ng/l

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.64

0.73

1.7

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.64

0.73

1.7

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.64

0.73

1.7

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

379

1.24

0.72

1.0

1.1

0.7

1.9

u/ml

1.38

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

0.72

1.2

2.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.80

0.72

1.4

2.0

16.5

17.6

umol/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.75

0.71

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.75

0.71

1.4

—

274.9

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.92

0.70

2.2

1.3

258.0

337.9

umol/24h

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.55

0.69

1.1

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.85

0.68

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.56

0.68

1.7

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1140

10994

1.04

0.68

2.9

3.2

2.5

mmol/l

0.43

946

9628

(3002523) Influenza virus A Ag [Presence] in Specimen

453

0.79

0.68

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

104

1.44

0.62

1.7

1.6

—

(4133840)

121

1.41

0.62

1.3

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.59

0.61

1.0

—

(3025130) Human papilloma virus identified in Specimen

307

1.24

0.60

1.5

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

456

0.81

0.60

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

139

1.37

0.60

1.2

29.5

35.8

0.27

(3034426) Prothrombin time (PT)

141

0.64

0.60

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

463

1.19

0.59

2.4

1.9

533.1

2227.8

u/l

1.15

179

(40768795) Lymph node Pathology biopsy report

553

0.83

0.59

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

658

1.16

0.59

1.9

1.8

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

114

1.40

0.58

1.0

2.3

1.5

1.1

ug/l

0.28

107

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

771

1.14

0.58

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

457

4328

1.06

0.58

2.5

2.1

11.3

12.5

nmol/l

2.23

381

3773

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.67

0.56

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

184

0.71

0.56

1.2

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

484

0.83

0.56

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

195

0.72

0.56

1.1

1.5

—

(3002619) Bacteria identified in Specimen by Culture

116

1.38

0.54

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

908

0.88

0.52

1.4

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

196

1.28

0.52

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

216

2003

1.08

0.52

1.8

—

(3010421) pH of Blood

164

1504

1.09

0.51

5.0

3.7

7.4

0.48

125

1259

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

358

0.81

0.50

1.6

1.4

49.1

162.6

pmol/l

0.62

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

118

1.36

0.50

1.0

1.1

89.0

82.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.56

0.48

1.0

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

4578

45385

1.03

0.48

22.5

16.2

38.0

39.1

8.34

2790

28660

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

119

1.35

0.48

1.0

1.2

88.1

83.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

189

0.74

0.48

1.2

1.4

—

(40768793) Breast Pathology biopsy report

974

0.89

0.47

1.4

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

102

1.37

0.47

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

188

0.74

0.46

1.1

1.4

—

(3044007) Cell count panel - Peritoneal fluid

155

1.29

0.46

1.9

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.37

0.44

2.9

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.43

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

139

1.30

0.43

1.1

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.61

0.43

1.4

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

144

1328

1.09

0.43

1.9

1.7

36.5

44.9

nmol/l

5.65

130

1264

(3020393) Adenovirus Ag [Presence] in Stool

1.43

0.42

1.0

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

469

4891

0.96

0.42

4.4

3.2

1.2

mmol/l

0.01

426

4156

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

131

1.30

0.42

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

295

1.19

0.41

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

295

1.19

0.41

1.4

1.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.52

0.41

1.0

1.5

15.8

26.7

pmol/l

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.41

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.41

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.41

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.41

0.0

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

286

1.19

0.41

1.1

1.3

0.4

1.7

u/ml

1.25

149

(3013862) HLA-DP [Type]

0.00

0.41

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

(3025315) Body weight

1.47

0.40

6.6

5.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

347

0.84

0.40

1.0

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

918

0.90

0.39

2.0

1.6

1.8

1.7

mmol/l

0.44

892

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.34

0.39

1.3

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.43

0.39

1.4

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.41

0.39

1.5

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

382

1.15

0.38

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.34

0.38

1.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

876

1.10

0.37

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

505

1.13

0.37

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

170

1.24

0.37

1.1

1.2

—

(44806420)

180

1.22

0.35

2.1

2.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.43

0.35

1.2

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

395

0.86

0.35

1.2

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

199

1.21

0.35

1.6

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

321

1.15

0.33

1.0

1.1

3.0

2.5

u/ml

0.13

120

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

118

1.27

0.33

1.3

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.28

0.32

1.2

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.30

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.71

0.30

1.7

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

304

0.85

0.30

4.7

4.4

26.8

90.7

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

111

0.72

0.28

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

251

1.16

0.28

1.8

2.8

36.2

37.4

0.12

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

140

0.79

0.28

1.0

1.4

310.8

140.5

nmol/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

461

1.11

0.27

1.1

1.2

3.6

u/ml

3.61

154

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

204

0.83

0.26

1.5

—

(3015183) Erythrocyte sedimentation rate

150

1.20

0.26

1.3

1.4

—

(4268621)

403

0.89

0.24

1.9

2.3

—

(3025577) Chromium [Mass/volume] in Blood

465

1.10

0.24

1.9

2.0

1.9

2.2

ug/l

0.59

391

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1466

14463

1.02

0.23

3.1

3.3

0.8

ug/l

0.41

1013

10290

(3001964) Herpes simplex virus Ag [Presence] in Specimen

134

1.19

0.22

2.0

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

228

1.14

0.22

8.0

4.0

35.7

55.8

u/ml

—

(44813793)

285

1.12

0.22

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

146

0.82

0.22

1.2

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

472

0.91

0.21

1.5

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

3.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

788

1.07

0.21

1.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

102

0.78

0.21

1.3

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.16

0.21

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.16

0.21

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.0

—

3.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

108

1.20

0.20

1.2

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.20

0.19

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.21

0.19

4.1

5.3

34.4

42.3

u/l

—

(4212803)

1.18

0.19

1.2

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

260

1.12

0.19

1.0

1.1

0.8

0.3

u/ml

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.13

0.18

10.0

6.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

195

0.87

0.17

6.5

6.0

—

(4034850)

169

1750

0.96

0.16

10.7

10.6

—

(1002224) Polysomnography panel

140

1348

1.04

0.15

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

672

1.06

0.15

1.4

24.1

28.8

iu/l

0.65

566

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.14

0.15

1.7

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.14

0.15

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.14

0.15

1.2

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

213

0.89

0.15

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

112

1.16

0.14

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

181

0.88

0.14

1.8

1.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

726

0.95

0.14

1.9

1.6

88.8

89.1

0.14

712

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

629

1.05

0.12

1.6

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

135

1.11

0.09

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.09

0.09

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.09

0.09

1.8

2.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.83

0.08

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.14

0.08

1.0

—

(3000012) Reticulocyte production index

357

0.95

0.07

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.07

0.07

1.7

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

539

0.96

0.07

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

246

1.06

0.06

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

127

1255

1.01

0.03

1.6

1.7

4.3

3.8

mg/l

0.11

894

(40759836) Histone Ab [Presence] in Serum by Immunoblot

300

0.97

0.03

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

191

1.05

0.03

1.0

1.1

8.2

4.3

u/ml

—

(40765096) Chromosome analysis panel by Banding

211

1.04

0.03

1.2

1.1

—

(3012501) Base excess in Blood by calculation

128

1293

0.99

0.02

4.7

3.8

2.2

2.6

mmol/l

1.16

101

876

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

279

0.97

0.02

1.7

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

172

1.05

0.02

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

248

0.97

0.02

1.5

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

601

1.02

0.02

1.1

1.2

1.8

5.2

u/ml

1.73

202

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

227

0.97

0.01

1.1

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

124

1.05

0.00

1.1

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

586

0.99

0.00

1.2

3.4

3.8

u/ml

0.15

261

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

303

0.99

0.00

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

303

0.99

0.00

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

303

0.99

0.00

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

156

1.03

0.00

1.8

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

111

0.99

0.00

3.0

2.8

509.6

1331.5

u/l

0.74

106

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

301

1.00

0.00

1.2

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

5.4

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

290

1.00

0.00

1.4

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.98

0.00

3.0

1.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

300

1.00

0.00

1.2

1.1

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

32.4

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

220

1.00

0.00

1.3

1.4

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.4

—

6.4

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

50.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.95

0.00

1.0

1.2

0.4

2.3

mmol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.87

0.00

1.7

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

610

1.00

0.00

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.97

0.00

1.1

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

2.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.02

0.00

1.3

1.5

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FH and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_FH	1.354 [1.23, 1.49]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.143

During the follow-up period (1.1.1998 — 31.12.2019), 6158 out of 21580 females with E4_FH died.

Males

Parameter	HR [95% CI]	p-value
E4_FH	1.442 [1.31, 1.59]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 7033 out of 24176 males with E4_FH died.

Mortality risk

Mortality risk for people of age

years, who have E4_FH.

N-year risk	Females	Males
1	0.123%	0.314%
5	0.761%	1.636%
10	1.933%	4.213%
15	3.509%	8.179%
20	6.254%	13.691%

Relationships between endpoints

↥

Index endpoint: E4_FH – Familial hypercholesterolemia

GWS hits: 30

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Familial hypercholesterolemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints